Podcasts about CGM

Insulin Resistance, Fertility, and Taking Your Health BackInsulin resistance doesn't just affect blood sugar — it impacts hormones, fertility, energy, and long-term health.In this episode, Tracy sits down with PA and women's health coach Chelsea Hayman to unpack how insulin resistance shows up in real life, why “normal labs” don't always tell the full story, and what clinicians and patients can do to break the cycle of crashes, cravings, and burnout.They explore fertility struggles, continuous glucose monitors, stress physiology, and practical strategies for stabilizing hormones and blood sugar — without extreme diets or unsustainable routines.Whether you're supporting patients with PCOS, infertility, fatigue, or metabolic dysfunction — or navigating this yourself — this conversation will change how you think about women's health.How insulin resistance affects fertility and hormone balanceWhy A1C can be normal — and problems still existThe “protein + fiber first” strategyHow stress worsens blood sugar regulationWhen CGMs can be helpful (even without diabetes)Small, sustainable changes that actually workWhy women must stop putting their health lastTimestamps:[2:30] Meet Chelsea Hayman[3:30] Blood Sugar and Fertility [4:45] Chelsea's Struggles with Infertility [9:00] Defining Insulin Resistance [11:00] Blood Sugar Control & Fertility Outcomes[13:00] Stress & Hormones[16:00] Implementing Lifestyle Changes [17:00] Choosing a Continuous Glucose Monitor [23:00] How to Plan Your Plate [25:00] Self Care & Meeting Your Own Basic Needs[29:00] Connect with Chelsea & Where to Find HerConnect with Chelsea: Website: www.empowerglucose.comLinkedIn: http://linkedin.com/company/empoweredglucose Social: @empoweredglucose at https://www.instagram.com/empoweredglucose/ Keywords: insulin resistance, blood sugar, hormone imbalance, fertility, infertility, PCOS, continuous glucose monitor, CGM, women's metabolic health, metabolic health, PA podcast, women's health, wellness, clinician wellness, hormones, gestational diabetes, insulin resistanceSPONSORS:ADVANCED PRACTICE PLANNING, LLC: advancedpracticeplanning.com/fiSIDE GIG GUIDE https://www.tracybingaman.com/gigCONNECT ⁠FREE 30-MINUTE COACHING CONSULT⁠ ⁠⁠https://calendly.com/the-pa-is-in/gen-call⁠ ⁠ ⁠1-ON-1 NEGOTIATION CONSULT ⁠https://calendly.com/the-pa-is-in/negotiate⁠⁠CONNECT WITH TRACY⁠LINKEDIN ⁠https://www.linkedin.com/in/tracybingaman/⁠⁠⁠INSTAGRAM ⁠https://www.instagram.com/mrstracybingaman/⁠⁠WEBSITE⁠ ⁠⁠⁠https://www.tracybingaman.com⁠

Anais, a scientist in the biotech industry, details her daughter Lira's first year following a Type 1 Diabetes diagnosis at age six. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Rachel Smith is an OB-GYN, lifelong mountain-lover, and person with type 1 diabetes who set out to summit Mount Vinson, Antarctica's tallest peak, in some of the harshest conditions on the planet. After climbs like Kilimanjaro and Aconcagua, she realized the biggest curiosity was not just the summit itself, but the diabetes strategy behind it: insulin safety, altitude, tech failures, and what it takes to navigate unpredictable blood sugars when you are far from help.In this episode, Rachel takes us into a 13-day Antarctica expedition (8 days on the mountain), where the sun never sets, the cold hits -50°C, and even treating a low can become complicated. You will hear what surprised her most, what she would do differently next time, and the message she wants every person with diabetes to carry with them: progress over perfection, and your goals do not have to shrink because you have T1D.WHAT WE COVER:Why Rachel chose Mount Vinson and why she decided to share the diabetes side publicly this timeThe realities of climbing in Antarctica: 24-hour daylight, extreme cold, and carrying everything yourselfManaging T1D on Kilimanjaro (manual testing) vs. Aconcagua and Vinson (pump + CGM)What happens when diabetes tech fails at altitude and in the cold (pump alarms, sensors cutting out)How Rachel kept insulin from freezing and built in backups (including guide support)Fueling strategy on long climb days: lower-carb mornings, steady carbs during breaks, and why it matteredSafety conversations with guides: how hypoglycemia symptoms can mimic altitude sicknessKEY TAKEAWAYS:1️⃣ Your plan needs redundancy. Remote climbs demand extra supplies, backup delivery methods, and contingency plans for freezing, loss, and tech failure.2️⃣ The environment changes everything. Altitude, cold, disrupted routine, stress hormones, and long-duration exertion can make blood sugars feel unlike your norm. That is not failure, it is data.3️⃣ Zoom out to rebuild trust. Rachel's CGM graphs looked more stable in hindsight than they felt in the moment, which is a reminder not to let one chaotic window define your confidence.WHAT'S NEXT:

This bonus episode takes you behind the scenes of a moment that made many people with Type 1 diabetes feel truly seen. Lauren visits Breakthrough T1D headquarters in New York City to sit down with Pam Morrisroe and uncover how the T1D Barbie went from an idea to a global symbol of representation. Pam shares her role in bringing community voices into the process and why getting the details right was not just important, it was everything.What unfolds is a powerful conversation about visibility, confidence, and the emotional weight of representation for kids and adults living with an often invisible condition. This episode is not about perfection or optics. It is about normalizing devices, embracing difference, and shifting the narrative from hiding diabetes to owning it with pride.WHAT WE COVER:How Mattel and Breakthrough T1D partnered to create the T1D BarbieWhy community input was essential in the doll's designThe intentional choices behind the CGM graph, pump number, and devicesNavigating criticism and misconceptions around representationWhat visibility means for kids growing up with Type 1 diabetesKEY TAKEAWAYS:1️⃣ Representation matters, especially for an invisible condition like Type 1 diabetes2️⃣ Getting it perfect is not the goal. Getting it real is what builds confidence3️⃣ Embracing what makes you different can change your entire relationship with T1DWHAT'S NEXT:

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: (Stacey Track) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. We are less than one month from our first MNO of 2026. Please join us in Silver Spring MD Feb 20 and 21. It's going to be amazing. We're going to Nashville next March 6-7 and we're going to have a great event a Club 1921 we just added on Thursday March 5th for health care providers and patient leaders. All the info is over at diabetes-connetionss.com events/ Okay.. our top story this week: XX   All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. This is the ELSA study - Early Surveillance for Autoimmune diabetes, a first of its kind UK study. They tested blood samples from 17,931 children aged 3-13 for autoantibodies, markers of type 1 diabetes that can appear years before symptoms. Families of children found to have early-stage type 1 diabetes received tailored education and ongoing support to prepare for the eventual onset of type 1 diabetes symptoms and to ensure insulin therapy can begin promptly when needed, reducing the chances of needing emergency treatment. Those with one autoantibody also received ongoing support and monitoring.   Some families were also offered teplizumab, the first ever immunotherapy for type 1 diabetes, which can delay the need for insulin by around three years in people with early-stage type 1 diabetes. The second phase has launched and will expand screening to all children in the UK aged 2-17 years, with a focus on younger children (2-3 years) and older teenagers (14-17 years). The research team aims to recruit 30,000 additional children across these new age groups. ELSA 2 will assess how screening can be scaled across the NHS and evaluate its cost-effectiveness. https://www.birmingham.ac.uk/news/2026/childhood-type-1-diabetes-screening-is-effective-and-could-prevent-thousands-of-emergency-diagnoses XX At the J.P. Morgan Healthcare Conference Dexcom CEO Jake Leach says they're going to launch a new product outside the US. I'll link up that interview, The full quote: "When you look at the outside the U.S., there are a lot of structures that are tiered. Patients have access to different types of products, so we've got a new one that we want to introduce that will add flexibility there. It's based on the G7 platform, just like Dexcom ONE+, but it has a unique experience that's tailored for a subset of users that, today, don't have access to Dexcom." Your guess is as good as mine, but sounds more like a pricing or ordering issue than a new bit of hardware or software. Dexcom will also bring Stelo to some international markets this year. And plans a new mobile app experience for the wearable biosensor meant for people who don't dose insulin. Leach also says G8 will be much smaller and with more capability. but is a few years away. https://www.drugdeliverybusiness.com/dexcom-ceo-jake-leach-2026-roadmap-jpm/ XX A new international consensus statement provides guidance for the use of diabetes technology during pregnancy for women with type 1 diabetes (T1D), type 2 diabetes (T2D), or gestational diabetes (GD).   Organized by the diaTribe Foundation, the document was based on evidence where available, as well as opinion from an international group of experts in endocrinology, diabetes technology, and obstetrics & gynecology, among others.   This is the first set of recommendations specifically addressing the use of diabetes technology in pregnancy – and we'll link it up. https://www.medscape.com/viewarticle/new-consensus-statement-addresses-diabetes-tech-pregnancy-2026a100020d XX Bariatric surgery beats GLP-1s for type 2 diabetes across income levels. This study was published this month, looking at nearly 300 patients are 4 medical centers. Success here is measured by lower blood glucose levels, higher weight loss (28% vs. 10%), less use of diabetes medications, remission of diabetes to the point of no longer needing to inject insulin, and reduced risk factors for cardiovascular disease.     Bariatric surgery was better than medical therapy across all social backgrounds, they found, and not just in areas of higher deprivation. The ancillary study was smaller, and some of the participants randomized in earlier stages crossed over from medical to surgical treatment, and the reverse. The authors acknowledged and accounted for these limitations, along with the rapid development of more powerful obesity drugs not fully captured in the study. This was a long term study – more than 12 years – and by the end of the study more people were choosing GLP1 medications. One dividing line: If someone hopes to lose 100 pounds, that's more likely with surgery than with medications.  "Ultimately, we need large, long-term, well-designed studies to clarify the best strategy for a given patient." https://www.statnews.com/2026/01/19/diabetes-study-bariatric-surgery-better-than-glp-1s/ XX Researchers at the University of California, Riverside have reported for the first time that a father's exposure to microplastics (MPs) can lead to metabolic problems in his children, including diabetes. This is a mouse study, but it looks at a previously unrecognized way in which environmental pollution may influence the health of future generations. MPs are extremely small plastic fragments, measuring less than 5 millimeters, that form as consumer products and industrial materials break down. Metabolic disorders describe a group of conditions that include elevated blood pressure, high blood sugar, and excess body fat, all of which raise the risk of heart disease and diabetes. The team found that female offspring of male mice exposed to MPs were far more prone to metabolic disorders than offspring of unexposed fathers, even though all offspring received the same high fat diet.     The research team hopes the findings will guide future investigation into how MPs and even smaller nanoplastics affect human development.   https://scitechdaily.com/microplastics-can-rewire-sperm-triggering-diabetes-in-the-next-generation/ XX The FDA has finalized four new recalls for certain lots of Abbott's FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to ongoing safety concerns. We told you about this in November when Abbott says some of its continuous glucose monitoring (CGM) sensors were providing incorrect low glucose warnings. Internal testing identified the issue—carbon building up in the sensors during the manufacturing process—and determined that approximately 3 million CGM sensors were affected. The sensors were distributed in the United States, Canada and several European countries.  When Abbott shared that announcement, the FDA was still reviewing the situation. No recalls had yet been finalized. Now, however, the agency has announced four new Class I recalls.   https://cardiovascularbusiness.com/topics/clinical/heart-health/fda-confirms-recalls-abbott-cgm-sensors-new-lawsuit-alleges-company-concealed-information XX   Insulet brings back it's U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them to a company specializing in recycling for electronics and medical products. Insulet began recycling pilot programs in Mass and California and are rolling it out nationwide. Insulet also has "Pod takeback" programs outside the U.S. in several international markets. These programs enable customers to request a takeback kit by contacting their local customer support team.   https://www.drugdeliverybusiness.com/insulet-expands-us-pod-recycling-program/ XX Up next a new resource for a population at three times the risk for diabetes, but without a lot of access to health information. I The first diabetes information website primarily in ASL has launched. The site includes GIFs and videos on diabetes management and an ASL glossary of diabetes-related terms. This is from University of Utah Health – Called Deaf Diabetes Can Together. Deaf and hard of hearing people are at three times higher risk for diabetes, but access to health information in ASL is limited. https://healthcare.utah.edu/newsroom/news/2026/01/first-diabetes-information-website-asl-launches XX Novo Nordisk ended all work on cell therapies, including a Type 1 diabetes program, in October – and now has found a buyer. Aspect has acquired rights to the assets and giving Novo an option to reengage for later-stage development and commercialization. Novo is helping bankroll Aspect's development of the assets, investing in the company and providing research funding. The arrangement gives Novo a chance to profit from the programs down the line. Novo is eligible for royalties and milestone payments on future product sales and, having handed the reins to Aspect for now, can expand its role in later-stage development and commercialization. The integration will involve the transfer of capabilities and expertise from Novo sites in Denmark and the U.S. to Aspect's Canadian operations. https://www.fiercebiotech.com/biotech/novo-nordisk-offloads-diabetes-assets-aspect-amid-cell-therapy-retreat XX XX Lucas Escobar has carved a role by proving that healthcare marketing can be culturally resonant, commercially powerful and deeply human. As director and head of U.S. consumer marketing at Insulet, he has redefined how the Omnipod tubeless insulin pump shows up in culture, transforming a medical device into a symbol of identity, inclusion and empowerment.   Under Escobar's leadership, Insulet launched three breakthrough initiatives: Dyasonic: Sound of Strength, a Marvel comic collaboration introducing a superhero who uses Omnipod; The Pod Drop, which turned the sound of a pod change into a celebratory music track; and Omnipod Mango x Pantone, medtech's first color partnership, honoring the vibrancy of the diabetes community. Each blended creativity with purpose while driving results, helping fuel Omnipod's consistent double-digit growth and its position as the most prescribed insulin pump in the U.S.   Living with type 1 diabetes himself, Escobar brings lived experience to his work, using storytelling not just to sell, but to make people feel seen.   Click here to return to the 2026 MM+M 40 Under 40 homepage.   From the January 01, 2026 Issue of MM+M - Medical Marketing and Media https://www.mmm-online.com/40-under-40/40-under-40-lucas-escobar-insulet/ -- FDA approves an update to the prescribing info for Afrezza inhaled insulin. This is a revision to the recommendations for the starting mealtime dosage when patients switch from shots or insulin pumps. This is aimed at healthcare providers - the updated labeling was supported by results from the INHALE-3 trial. The FDA is still considering approval of Afrezza for kids – a decision there expect by summer. https://www.globenewswire.com/news-release/2026/01/26/3225442/29517/en/MannKind-Announces-FDA-Approval-of-Updated-Afrezza-Label-Providing-Starting-Dose-Guidance-when-Switching-from-Multiple-Daily-Injections-MDI-or-Insulin-Pump-Mealtime-Therapy.html   -- UK researchers have developed a calculator to predict whether someone is at risk for type 1 diabetes. They're hoping this helps in screening and in preventing DKA at diagnosis. They used the TEDDY study to create this calculator, which right now is in beta form and only for kids and teens ages 8-18. The current beta form of the calculator asks users to answer questions about four factors necessary to estimate a child's risk of developing type 1 diabetes: age, family history, number of confirmed autoantibodies, and genetic risk score. The calculator has been given regulatory approval as a diagnostic in the U.K., and he's working with a company that's hoping to bring it to the U.S. in the next few months in the form of a home genetic test kit. https://www.healthcentral.com/news/type-1-diabetes/new-calculator-might-help-predict-type-1-diabetes-before-symptoms-appear

Protecting your ideas can be the difference between building momentum and watching someone else run with your work. In this episode of Unstoppable Mindset, I sit down with patent attorney and entrepreneur Devin Miller to explore what founders and business owners really need to know about patents, trademarks, and intellectual property. Devin shares how his background in engineering, startups, and law shaped his approach to innovation, and he breaks down the real differences between provisional and non-provisional patents in clear, practical terms. We talk about common mistakes entrepreneurs make, how legal protection supports growth instead of slowing it down, and why understanding intellectual property early can help you compete with confidence. I believe this conversation will give you clarity, direction, and a stronger foundation for protecting what you work so hard to create. Highlights: 00:01:18 – Hear how growing up in a small town shaped Devin's approach to problem-solving and business.00:12:53 – Learn why Devin combined engineering, business, and law instead of choosing a single career path.00:19:32 – Discover how a student competition turned into a real wearable technology startup.00:30:57 – Understand the clear difference between patents, trademarks, and copyrights.00:33:05 – Learn when a provisional patent makes sense and when it does not.00:53:52 – Discover what practical options exist when competitors copy or knock off your product. About the Guest: Devin Miller is the founder of Miller IP, a firm launched in 2018 that helps startups and small businesses protect their inventions and brands without breaking the bank. He's overseen over a thousand patent and trademark filings with a 95 percent success rate on patents and an 85 percent success rate on trademarks, making sure garage inventors and side hustlers get the same high-quality service as big tech. Before starting his firm, Devin spent years at large law firms working with clients like Intel and Amazon, but he found his true passion in helping scrappy entrepreneurs turn ideas into assets. He blends legal know how with an entrepreneur's mindset, offering flat fee packages, DIY legal tools, and hosting webinars and a podcast series to demystify IP. A lifelong runner who knocks out 10+ miles a day and 30-40 miles daily biking (except Sunday), Devin listens to audiobooks and podcasts while training for marathons. When he's not drafting office action responses or co-hosting Inventive Journey, you might catch him brainstorming the next Inventive Youth program or sipping coffee while sketching partnership agreements. Ways to connect with Devin**:** If you'd like to talk strategy or swap running playlist recs, feel free to schedule a chat at http://strategymeeting.com LinkedIn profile  https://www.linkedin.com/in/lawwithmiller/ Firm website [https://www.lawwithmiller.com](https://www.lawwithmiller.com "https://www.lawwithmiller.com") About the Host: Michael Hingson is a New York Times best-selling author, international lecturer, and Chief Vision Officer for accessiBe. Michael, blind since birth, survived the 9/11 attacks with the help of his guide dog Roselle. This story is the subject of his best-selling book, Thunder Dog. Michael gives over 100 presentations around the world each year speaking to influential groups such as Exxon Mobile, AT&T, Federal Express, Scripps College, Rutgers University, Children's Hospital, and the American Red Cross just to name a few. He is Ambassador for the National Braille Literacy Campaign for the National Federation of the Blind and also serves as Ambassador for the American Humane Association's 2012 Hero Dog Awards. https://michaelhingson.com https://www.facebook.com/michael.hingson.author.speaker/ https://twitter.com/mhingson https://www.youtube.com/user/mhingson https://www.linkedin.com/in/michaelhingson/ accessiBe Links https://accessibe.com/ https://www.youtube.com/c/accessiBe https://www.linkedin.com/company/accessibe/mycompany/ https://www.facebook.com/accessibe/ Thanks for listening! Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page. Do you have some feedback or questions about this episode? Leave a comment in the section below! Subscribe to the podcast If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can subscribe in your favorite podcast app. You can also support our podcast through our tip jar https://tips.pinecast.com/jar/unstoppable-mindset . Leave us an Apple Podcasts review Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts. Transcription Notes: Michael Hingson  00:00 Access Cast and accessiBe Initiative presents Unstoppable Mindset. The podcast where inclusion, diversity and the unexpected meet. Hi, I'm Michael Hingson, Chief Vision Officer for accessiBe and the author of the number one New York Times bestselling book, Thunder dog, the story of a blind man, his guide dog and the triumph of trust. Thanks for joining me on my podcast as we explore our own blinding fears of inclusion unacceptance and our resistance to change. We will discover the idea that no matter the situation, or the people we encounter, our own fears, and prejudices often are our strongest barriers to moving forward. The unstoppable mindset podcast is sponsored by accessiBe, that's a c c e s s i capital B e. Visit www.accessibe.com to learn how you can make your website accessible for persons with disabilities. And to help make the internet fully inclusive by the year 2025. Glad you dropped by we're happy to meet you and to have you here with us. Well, hello to all of you, wherever you happen to be today, you are listening to or watching or both unstoppable mindset and I am your host. Mike hingson, our guest today is Devin Miller, who founded the company, Miller IP, and he'll tell us all about that and what that means and so on as we go through this. But I will tell you that he is a lawyer. He deals with patents and other things and a lot of stuff relating to startups. I think that's going to be a lot of fun to talk about. So without any further ado, as it were, Devin, welcome to unstoppable mindset. We're really glad you're here. Thanks for having me on. Excited to be here. Well, we're glad. We're glad you're here. Can you hear me? Okay, now I hear you. Devin Miller  02:06 Well, we're sorry for the delay, but I said I'm excited to be here and looking forward to chatting. Michael Hingson  02:11 Well, perfect. Well, let's start. I love to always do this. Let's start kind of at the beginning. Why don't you tell us about the early Devon, growing up and all that? Devin Miller  02:21 You know, I I'm happy to do. I don't know there's anything that probably stands out. I was probably fairly typical. So I was raised in a religious family, so we're attended church regularly every week. And I had a couple sisters, an older and a younger one, and was went through, went through schooling and or studied, probably the typical course. So I don't know there's anything stands out. I was in a small town, so grew up as, probably not as small as I'd like it to be anymore, but a small farming town, and it was, it was kind of always enjoyed the small town fill, and actually am back to being in that same hometown where I live now with my family. But yeah, so I did that, and I did probably the at the time, the typical thing with the it's growing up with kids and sports and doing things, and went through high school and and after that, jumped or went off to college. But I don't know if there's anything in particular that stands out in my mind, other than probably, at least in my mind, a pretty typical childhood and upbringing, but enjoyed it nonetheless. But happy to provide any details or I can jump into a bit about college. Michael Hingson  03:38 Well, where did you go to college? Devin Miller  03:40 Yeah, so I went to Brigham, young university, just or BYU, just out here in Utah. So I went off to so, or I graduated high school and I went off to a year of college. So I went off to BYU, kind of intending to go into electrical engineering, which is what I or one of the degrees I ended up studying with, and then I did that for a year, and after which I went off and did a served a religious mission for my church, so Church of Jesus Christ, or Latter Day Saints, otherwise nicknamed Mormon. So I went off and went to Taiwan for about two years. So didn't have any idea, even at that point where Taiwan was and certainly didn't know the language, but when studied that, or they have a training center where you get an opportunity to study it for about three months. So I studied it and then went off to Taiwan and served that religious mission for my church for a couple years before coming back to the high school, or good, not the high school to college to continue my studies. Michael Hingson  04:43 I several, several comments. One, I know what you mean about small hometowns. We moved from Chicago, where I was born, to California when I was five, we moved to a town called Palmdale, and it was a very small rural town about 60. Five miles north of Los Angeles. I don't know what the population was when we first moved there, but it couldn't have been more than 1000 or 1500 people spread out over a little bit of a distance. For me, it was great, because without there being a lot of traffic, I was able to do things I might not have done nearly as well in Chicago things like riding a bike, learning to ride a bike and walking to school and and not ever fearing about walking to school for any reasons, including being blind. But oftentimes I once I learned how to do it, I rode my own bike to school and locked it in the bike rack and then rode home and all that. But then Palmdale started to grow and I'm not quite sure what the population is today, but I live in a town about 55 miles east of Palmdale called Victorville, and as I described Victorville growing up, it was not even a speck on a radar scope compared to the small town of Palmdale, but we we moved down to Southern California from the Bay Area my wife and I to be closer to family and so on. In 2014 we wanted to build a house for Karen, because she was in a wheelchair her whole life. So we wanted to get a a house that would be accessible. And my gosh, the only place we could find any property was Victorville. And at that time, in 2014 it had 115,000 people in it. It has grown. Now it Devin Miller  06:31 has grown. And it tends to be that, you know, it feels like everybody's always kind of chasing the small town then, or people find out about it. Everybody moves in. It's no longer a small town, and then you're off to chasing the the next small town, wherever that might be. So it's kind of a perpetual cycle of of chasing that small or at least for the people to like it. Not everybody loves it, but I'm certainly a proponent of chasing that small town feel from from place to places, as you're trying to or trying to find or recreate what you probably grew up with. So it is a it is a cycle that everybody I think is chasing, Michael Hingson  07:09 yeah, well, for me now, my wife passed away in 2022 we were married 40 years. And so the thing about it is that there are probably advantages for me living alone, being in a place that has a few more people and a few more of the kind of amenities that at least somewhat larger towns have, like a Costco and some some restaurants. We actually live in a homeowner's development, a homeowner's association called Spring Valley Lake, and I live within walking distance of the Country Club, which has a nice restaurant, so I'm able to go to the to the restaurant whenever I choose, and that's kind of nice. So there's value for me and being here and people say, Well, do you ever want to move from Victorville now that your wife died? And why do I want to do that? Especially since I have a 3.95% mortgage? You know, I'm not going to do that, and I'm in a new house that. Well, relatively new. It was built in 2016 so it's pretty much built to code. And insulation is great. Solar is great on the house. Air conditioning works, so I can't complain. Devin Miller  08:20 No, sounds like a good setup, and it's kind of one where, why, if you enjoy where you're at, why would you move to go somewhere else that you wouldn't necessarily enjoy? So it just sounds like it works out. Michael Hingson  08:29 Well, it does, and I can always, as I need to being a keynote speaker and traveling, there's a shuttle that'll take me down to the nearest airports. So that works out. Well, that's awesome. So you went to, I'm a little bit familiar with the the whole LDS missionary program, Mission program, we we were not part of the church, but we lived, when my wife and I got married, we lived in Mission Viejo and we had neighbors right next door to us, who were members of the church, and they came over one day and they said, we have an issue. And I said, Okay. And my wife said, Okay, what's the issue? Well, we have a couple of missionaries coming in, and the only homes that are available to these two boys are homes that already have young female girls in them. So they really can't be in those homes. Would you be willing to rent your one of your rooms to missionaries? And so we said, and well, Karen said, because she was a member of the Methodist church, we said, as long as they don't try to mormonize us, we won't try to methodize them. And we would love to do it. And it worked out really well. We had a couple of missionaries for a while, and then they switched out. And eventually we had a gentleman from Tonga for a while, and we actually had a couple girls for for a while. So it worked out really well, and we we got to know them all, and it was a great relationship. And they did their work, and at Christmas time, they certainly were invited to our Christmas parties. We. Had every year a party. What we actually had was what we call a Christmas tree upping. We got the tree, we brought it into the house, and we invited all of our friends and neighbors to come and decorate the tree in the house. Because, needless to say, we weren't going to do that very well. Karen especially wasn't going to be able to stand up and decorate the tree. So we got them to do all the tree decorations and all that, and we fed them. So it worked out. Devin Miller  10:26 Well, it's awesome. Sounds like, great. And you hit on. I said, that's probably my, my favorite part of the Christmas is a Christmas tree. So growing up, we always had a real live tree, but it was always, you know, it was downstairs in the basement, and had lower ceilings. And so I was always kind of the opinion, hey, when I grow up, I want to have the a huge, you know, kind of like in the newbies at 20 plus or 20 or 20 plus foot tree, yeah. And lo and behold, we, or at least the couple houses that we build have always had, at least in the living space, have had the pretty high ceilings. And so that's always what we do. We'll go out and we'll cut down a live tree. So we'll go out to kind of in nature, to the forest, where they let you cut them down, and we'll, we'll cut down, usually it's around a 20 plus foot tree, and then have it strung up in the house. And I always tell my wife, I said, I'd rather that one could be my Christmas present. I'd be just as happy, because as long as I have my tree, it's a good Christmas for me. Michael Hingson  11:23 Yeah, oh, I hear you. Well, one of the boys who lived next door to us went off on a mission to, I think it was Argentina, and was gone for, I guess, two years. What was really funny is when he came back, it took him a while to re acclimatize his speaking English and getting back his American accent. He was he definitely had much more of a Spanish accent, and was much more used to speaking Spanish for a while. So the the three month exposure period certainly got him started at the at the center there in Utah. And then he went off and did his missionary work and then came home. But, you know, it's, it's got to be a wonderful and a very valuable experience. How do you think it affected you? Devin Miller  12:10 Yeah, I think I said, I think it would be, you said it probably well, is it like one where to say, Hey, this is the most fun time in your life, and you'll never have a more fun time. I don't know that. It's kind of like, you know, I liken it to I so I like to do a lot of running, so or in older years. I don't know that I was as much in younger years, but kind of discovered not that I love running, per se, but love to get out and decompress and otherwise, kind of have a time where I don't have a lot of intrusions or other things that are pressing in on life. And so with that, you know, I've done a number of marathons and marathons, you know, everybody again, says, Well, did you have fun? Or was it a good or was it good marathon? So I don't know that it's ever fun. I don't and do it, but it's a good accomplishment. You it's, you go out, you set your mind to something, and then otherwise, at the end of the day, you reach your goal. And, you know, kind of has the that sense of accomplishment and learning and become improving yourself. That's probably a lot of how I like in a mission is, you know, you have a lot of stresses of learning a new language, being in a different culture, doing something that you're unfamiliar with or not accustomed to, and at the end, you know, you learn a lot of things, you are gain a lot of skills. You hopefully impact a lot of people's lives for the better. And so it is definitely one of those where it's a great accomplishment, but it's not, you know, it's not one way to say, hey, this was a fun vacation where I got to go play for two years. So it it works out well, and I would absolutely do it again. Michael Hingson  13:31 Yeah, I'm sure you learned a lot, and you probably learned a whole lot more in a lot of ways, than most of the people that you you visited with because you treated it as an adventure and an adventure to learn. So that's pretty cool, absolutely. So you came back from that and you went back to college, and did you continue in electrical engineering? Or what Devin Miller  13:56 did you do? Yes and no. So I did continue in electrical engineering. Or so I came back and, you know, the intent was, and what I continue to do is to study electrical engineering. I did add on a second degree, which I was a Mandarin Chinese and so I can't remember, I mentioned I I served in Taiwan for those couple years and had an opportunity to kind of, you know, learn and study the language. So as I was doing that, I kind of came back and said, Well, if I've already put in the effort to learn the language and to study it, I might as well, you know, utilize it, or add it to the degree. And so I I really started, or I added that as a second degree to the first degree. So I came out with both the degree in Chinese or man or Chinese, as well as electrical engineering. So yes, continue to study that. And then from that, you know, kind of just as a part of that story. So I was coming out, kind of getting, you know, the senior year, kind of getting towards the end of that degree, and looked at and said, you know, what do I want to do when I grow up? And I still know if I know the full answer, but I did look at it and say, Hey, I, you know, I don't know exactly what I want to do when I grow up, but I don't, I like engineering. Engineering, but I don't want to be an engineer in the sense that, you know, not that I didn't like engineering, but it was one where a typical electrical engineers, you come out of graduate school, you go work for a big company. You're a very small cog and a very big Will you work for. You know, 1015, years, you gain enough experience to have any say your direction and what projects you work on or really have any impact. Not saying that's not really what I want to do when I grow up, or when I start into the working world. And so kind of with that, I, you know, I had a couple interests I enjoyed, you know, kind of the startup, small business, kind of that type of world. And I also found it interesting to on the legal aspect of intellectual property, so patents, trademarks, and really more. At the idea of, hey, you're going to work with a lot of cooling or cool inventions, cool people are working on a lot of unique things, and you get a lot more variety. And you get, you know, kind of be more impactful. And so that was kind of the the Crossroads I found myself at saying which, you know, kind of which direction I want to go. And, you know, kind of, rather than take one or the other, I kind of, I split the road and decided I was going to do both. So I went off to graduate school and did both an MBA or a master's in business administration as well as a law degree, kind of focused more on intellectual property. So went off and studied both of those kind of with the intent of, you know, I don't want to just be fit into one box or do just one thing, but I'd like to keep a foot in the business world, startup world, and have an opportunity to pursue my own business as well as doing the law degree. So I did that in a Case Western Reserve out in Cleveland, Ohio, studying both of those degrees Michael Hingson  16:34 when you were getting your degree in manner, in Chinese. Was that all about speaking the language, or was it also involved in history and civilization and understanding more about China? What was it like? Devin Miller  16:47 It was really more, certainly, there was a or, I guess, are you saying within college or within the mission itself? 16:54 In college? Okay, yeah. I mean, it was, Devin Miller  16:57 it was still primarily focused on the language. You know, the nice thing is, you can test out of a number of the, you know, entry level or their beginning classes, as long as you can show a proficiency. So there may have been some of that, and you still got, you know, some of the classes, would you still study a little bit of poetry, or, you know, within the language context, they've used poetry as a way to kind of learn different aspects of the language. You'd get a little bit of history, but pretty, or vast majority of focus was kind of both speaking as well as the the written and, you know, those are really as opposed to, like English speaking, where it's phonetics and you can or sound out and kind of understand what a you know, what something means by sounding it out, you don't have to know the word in order To, you know, to pronounce it. Chinese is not that way. So you have characters that are just every character you have to memorize. There is no phonetics. There's no way that you can look at a character and sound it out. And so there's a large amount of just memorizing, memorizing, you know, 20,000 characters to read a newspaper type of a thing. And then on the flip side is you have to learn the language, which is, you know, which are already focused on that, more on the mission, but you have to do pronunciation, so you can say the same word with different tones and it has entirely different meaning. So really, there was enough there on the language side, they tended to primarily focus on that, just because there was quite a bit there to Michael Hingson  18:19 dive into. It's a complicated language. Devin Miller  18:23 It it is certainly or uniquely different from English. I would say probably English to Chinese speakers is the hardest language because it's the most different from their language. And vice versa for English speaking Chinese is at least one of the this or harder languages because it is entirely different. So it is one that has a lot of intricacies that you get to learn. Michael Hingson  18:45 I took German in high school for three years, and then in college, I did a lot of shortwave listening and encountered radio Japan a bunch. So I actually took a year of Japanese, and I think from a written language, it's a lot more complicated than spoken language. I think it's a lot more straightforward than Chinese and a lot of ways easier to learn. But even so, it is different than than Latin languages by any standard. Devin Miller  19:16 But it is. It's an animal in and of itself, but it makes it fun. Michael Hingson  19:21 Yeah, that's right, it does make it fun. Incident. And then, as I said, it was an adventure. And all of that was, was an adventure. My master's is in physics. That was an adventure. And until you spend a lot of time dealing with physics and hopefully getting beyond just doing the math, you learn how much of a philosophical bent and how much about society and the way things work really is wrapped up in physics. So again, it's it's kind of fun, and unlike a lot of physicists or engineers. I've never thought that one is better or worse than the other. I think they both have purposes. And so as a physics person, I never pick on engineers. Devin Miller  20:11 I am, I wouldn't pick up. I wouldn't pick on any physics or physicists or physics majors, either, because that's equally, if not more difficult. And so there's a lot of learning that goes on and involved with all of them. But they're all of them are fun areas to Michael Hingson  20:26 study with. They are. So once you you got your master's degrees, and you you got your law degree, what did you go off and do? Devin Miller  20:36 Yeah, so I mean, I would probably back it up just a little bit. So kind of during that period where I was getting the degrees, couple things happened. Had a couple kids. So started out first kid while I was doing the, I guess the second year where I was in under or doing the law and MBA degree, doing it as a joint degree. And so had the had a kid. And then during that same period, the next year, about a year about a year and a half later, had another kid. And so that puts me as a it's a four year program, if you combine both of them together. And so I was in the kind of the third year, the four year program. And while I was doing those studies, you know, I had a I was doing a couple things. One is, I was doing the both, or studying both majors, raising the family. I was working about 20 hours as a law clerk or for a law firm, and then during that, I can't remember or if it was a flyer, or if it was, you know, an email or whatnot, but came across a business competition, or it's kind of a, it was kind of a, a multi disciplinary competition wherever, you know, people of different degrees and different fields of study would get together, you form a group of four or five, and you work on developing an idea, and then you would enter it into the competition and see how it goes. And so we did that the first year, and we did something, an idea to make Gym Bags less smelly, and then enter that in and took second place. And during that period, next year comes along, we're all in our final year of our degree. And as we're doing that, we are studying the degree and or entering the competition again. And we decided to do something different. It was for wearables. You know, this is before Apple Watch, or, you know, the Fitbit, or anything else. It was well before I knew that, but we just said, Hey, when I was there, thinking, hey, wouldn't it be cool I'd ran my or, I think, my second marathon that time. Wouldn't it be awesome if you could monitor your hydration level so that you can make sure you're staying well hydrated throughout and it helps with the air, not being a sore and being, you know, quicker recovery and performing better. And so out of that, took the genesis of that idea, entered it back into the business comp, or that is a new idea, into the business competition, and did that with the partners, and took second place again, still a little bitter, or bitter that about that, because the people that took first place has entered the same thing that they entered the previous year, but polished, or took the money they've earned previously and polished it made it look a little nicer, and won again because it looked the most polished. But that aside, was a great, or great competition. Enjoyed it. And from that, you know, said, Hey, I think this is a good idea. I think it can be a, you know, something that you could actually build a business around. And so said, Hey, or kind of told the the people that were in the the group with me, you know, we're all graduating. We're going different directions. Would be pretty hard to do a startup altogether. So why don't we do this? Or why don't you guys take all the money that I got, you know that we you're in some reward money, or, you know, prize money. If you take my portion, split it amongst yourselves, and I'll just take ownership of the idea, whatever it is, where, you know, wherever I take it, and simply own it outright, you know, basically buying them out. And so that's what I did. So coming out of, you know, getting the MBA in the law degree, that was kind of always the intent. So, or coming out of school, I went and joined a law firm here in Utah. Was a full time patent attorney, and then alongside, you know, had the side hustle, what I'd really say is kind of a second full time job to where I was, you know, pursuing that startup or small business alongside of doing the law firm. So that was kind of the the genesis for, as I graduated full time attorney working, you know, with a lot of our cool clients and other things, and then also incorporating the desire to do a startup or small business. And that's kind of been, really, the trajectory that I've taken throughout my career is really, you know, finding ways to combine or to pursue both interests together. Michael Hingson  24:26 What happened to the business? Devin Miller  24:28 Yeah, so it so it's still alive today. I've been, I exited. Now it's been a couple year and a half, two years somewhere in there. Have to think back. So it started out. So with the business I started out, it was actually one where, rewinding just a little bit when we when I got started, my dad was also an electrical engineer. He'd actually, you know, he's well or farther into his career, and he done a number of different things across their medical devices through his career. And so he kind of, or he joined on as kind of doing it with us. Hustle with me, and we took that, started to build it. We brought on some additional team members. We brought on an investor, and actually built out and grew the business. It also evolved. So we were starting to test or test out the technology have it with some colleges and some other, you know, athletes, which was a natural place to start it at and about that time, and we were getting kind of to that next hurdle where we either needed to get a further investment or cash infusion, you know, to kind of take it to a more of a marketable, you know, a except a Polish full or ready to go to market type of product. And at that time, as we're exploring that we had or came or got connected with somebody that was more in the diabetes monitoring, they were doing it more from a service base. But you know, the overlay as to kind of how the technologies are overlapped with what they're doing tended to work out pretty well. And so we ended up combining the business to be one, where it was redirected a lot of the technology we developed underlining to be more of a wearables for the diabetes monitor. So that was a number of years ago. I stayed on doing a lot of, some of the engineering and development, primarily more in the intellectual property realm, of doing a lot of patents and whatnot. And then about a year and a half, two years ago, got bought out, was exited from that company and and that continues on today. It's still alive and growing, and I kind of watch it from, you know, from a distance, so to speak, or kind of continue to maintain interest, but don't are not necessarily active within the business anymore. So that was kind of a long answer to a shorter question, but that's kind of where the business eventually evolved to. Michael Hingson  26:36 So now I'm sure that the company is doing things like developing or working with products like continuous glucose monitors and so on. Devin Miller  26:46 Yep, yeah, that's kind of the direction as to what they're headed you Michael Hingson  26:49 well, and what's what's been interesting about several of the CGM type devices is that for people who are blind, there's been a real push to try to get some of them to be accessible. And what finally occurred about a year ago, maybe two years ago, is that one of the devices that's out there was approved to actually incorporate an app on a smartphone, and when the app came out, then it was really easy, although it took an effort to convince people to pay attention to it and do it, but it became technically a lot easier to deal with access, because all you had to do was to make the app accessible. And so there now is a continuous glucose monitor that that is accessible, whereas you wherein you get all the information from the app through voiceover, for example, on the iPhone or through talkback on a android phone that you get when you're just looking at the screen, which is the way it really should be anyway, because If you're going to do it, you should be inclusive and make it work for everyone. Devin Miller  28:06 No, that's cool. Yeah, there's a number of I think, between, you know, being a prevalent, you know, issue that people are dealing with, to, you know, different trying to address things earlier on, and also to motivate people do healthier lifestyle. And kind of the direction I think, is headed where a lot of the the company that's continues on today, from our original technology, is on the non invasive side. So a lot of them have, you have to have a patch, or you have to have periodically prick, or put an arm, you know, arm, right? Something where has a needle in the arm. And this one is kind of trying hair working to take it to that next level, to where it's no longer having to be invasive, and it's really all without having air with sensors that don't require you to have any sort of pain or prick in order to be able to utilize it. So kind of fun to fun to see how the industry continues to evolve. Michael Hingson  28:55 Well, today, we're working on that, and tomorrow, of course, the tricorder. So you know, we'll, we'll get to Star Trek 29:03 absolutely one step at a time. Michael Hingson  29:05 Yeah, but I've kind of figured that people were certainly working on non invasive technology so that you didn't have to have the sensor stuck in your arm. And I'm not surprised that that that's coming, and we'll be around before too long, just because we're learning so much about other ways of making the measurements that it makes sense to be able to do that. Devin Miller  29:31 Yep, no, absolutely. You know, it is a hard nut to crack. The body is very complex. A lot of things going on, and to measure it, not invasively, is certainly a lot that goes into it, but I think there's a lot of good, good technologies coming out. A lot of progress is being made, and certainly fun to continue to see how the health devices continue to hit the market. So certainly a cool area. Michael Hingson  29:53 So why did you decide, or maybe it was a natural progression, but why did you decide to go into patent law? Yeah. Devin Miller  30:01 I mean, I think it was probably a natural progression, and in the sense that, you know, it is one where overall desire was, Hey, I like engineering from the sense I like to think or how things work and kind of break things down and to have a better understanding. So really, intellectual property law and patents and trademarks and others allowed me to work with a lot of startups and small businesses, see a lot of cool things that they're developing still play a hand in it, and yet, also not, you know, be mired down to a long project over multiple years where you, you know, you're a small cog in a big wheel. And so, yeah, that was kind of one where it fit well within kind of the overall business, you know, business desire and business aspect of what I wanted to accomplish, and also just overall, you know, enjoying it or enjoying it. So that's kind of where it might, you know, it married well with the the desire to do startups and small businesses, as well as to work with a lot of other startups and small businesses. Michael Hingson  30:55 That's a lot of fun, to be able to deal with startups and see a lot of new and innovative kinds of things. And being in patent law, you probably see more than a lot of people, which does get to be exciting in an adventure, especially when you see something that looks like it has so much potential. Yep. Devin Miller  31:14 No, it is. It is fun. I get to see everything from I've worked on everything from boat anchors to credit card thing or devices that help elderly people to remove them more easily, from their wallet to AI to drones to software other or software platforms to medical devices. So it gives a ability to have a pretty good wide exposure to a lot of cool, different, you know, very different types of innovations, and that makes her just, you know, a fun, fun time, and be able to work or work with the air businesses as they develop. Are all those different technologies? Michael Hingson  31:50 Well, on the the law side of things, what's the difference between a provisional patent and a non provisional filing? Devin Miller  31:57 Yeah, so, so I don't back it up, and I'll get to your question. But maybe I'd set the stages to when you're looking at what is the difference between a patent and trademark and copyright, because a lot of times when people look at that, that's probably a good question too. Provisional trademark, or I want a, you know, or a non provisional copyright, or whatever it might be, and kind of get the terminology mixed up. So if you're to take it one step back, a provisional patent app or a patent is something that goes towards protecting an invention. So something that has the functionality that does something, that accomplishes something, a trademark is going to be something that is protecting of a brand. So name of a company, name of a product, a cash, phrase, a logo, and those type of things all really fall under trademarks and copyrights are going to be something that's more creative in nature. So a painting, a sculpture, a picture, a book, you know, all those type of things are going to fall under copyrights. And so really, when you're looking at it, you know, kind of breaking it down initially, you look at it as you know, which one is it. And so now to your question, Michael Hingson  32:58 well, before you go there, before you go ahead, before you go there. So if I'm writing software, does that fall under patent or copyright? I would assume if the software is to do something, it would be a patent. Devin Miller  33:12 So software primarily is under a patent. So there's, technically, you can copyright software. Now there's, it's pretty limited in its scope of protection. So if you're to do or software and do it under a copyright, really, all it protects is the exact way that you wrote the code. So you know, got it using this exact coding language. If somebody come along, copy and paste my code, you'll be protected. But it doesn't protect the functionality of how this code works or what it does. It is purely just how you wrote the code. So most of the time, when you're looking at software, it's really going to be more under a patent, because you're not going to want to just simply protect the identical way that you wrote the code, but rather what it does and what it does, yeah. So yep. So yeah, you for if you're to do as as your example, software, primarily, you're going to it's going to fall under patents. Michael Hingson  34:01 Okay, so anyway, back to provisional and non provisional. Devin Miller  34:05 Yeah, so, and when you're looking at doing a patent, you can do there's a couple different types of patents. One is a design patent. It really just goes to something the esthetic nature, the look and feel of a of an invention. So if you're thinking of the iPhone, you know, used to have the curved edges. I had the circle or a button at the bottom. It had, you know, the speaker placement and all those things. And it was just that outward appearance, not the functionality, could go under a design patent, but what the primary patent, which is what most people pursue, is what's called the utility patent application. And the utility patent application is really going towards the functionality of how something works. So the utility, how it works, what it does, and then kind of the purpose of it. And so with that, when you're looking at pursuing a utility patent application, there are a couple different types of patents that you can or types of utility patent patent applications. So. As you mentioned, one is called a provisional patent application. The other one is called a non provisional patent application. So a provisional patent application is kind of set up primarily, a lot of times for startups or small businesses where they're going to have a some product or an innovation that they're working on. They're in earlier stages. They're wanting to kind of protect what they have while they continue to develop it, and kind of flush it out. So provisional patent application is set up to be a one year placeholder application. So it will get, you know, you file it, you'll get patent pending, you'll get a date of invention, and it'll give you a year to decide if you want to pursue a full patent application or not. So you can file that gives you that one year time frame as a placeholder. The non provisional patent application would be the full patent application. So that would be what has, all the functionality, all the features, all the air, formalities and air, and it will go through the examination process. We'll go look at it for patentability. So those are kind of the difference provisional, one year, placeholder, less expensive, get your patent pending, versus the non provisional, that's the full patent application and gives you kind of that, or we'll go through examination. Michael Hingson  36:12 Do most people go through the provisional process just because it not only is less expensive, but at least it puts a hold and gives you a place. Devin Miller  36:22 It really just depends on where people are at. So kind of, you know, a lot of times people ask, Hey, well, what would you recommend? And I'll usually say, hey, there are typically two reasons why I would do a provisional patent application. And if you don't fall into either of those camps, then I would probably do a non provisional patent. Got it. So generally, the two reasons I get one is certainly budgetary. Give you an example. So our flat fee, you know, we do our primarily everything, flat fee in my firm, and a provisional patent application to prepare and file it, our flat fee is 2500 versus a non provisional patent application is 6950 so one is, Hey, your startup, small business, to have a limited funds, you're wanting to get a level of protection in place while you continue to pursue or develop things, then you would oftentimes do that as a provisional patent application. And the other reason, a lot of times where I would recommend it is, if you're saying, Hey, we've got a initial innovation, we think it's going to be great. We're still figuring things out, so we'd like to get something in place while we continue to do that research and develop it and kind of further figure it out. So that would be kind of, if you fall into one of those camps where it's either budgetary overlay, or it's one where you're wanting to get something in place and then take the next year to further develop it, then a provisional patent application is oftentimes a good route. There are also a lot of clients say, Hey, I'm, you know, we are pretty well. Did the Research Development getting ready to release it in the marketplace. While we don't have unlimited funds, we still have the ability to just simply go or go straight to a non provisional so we can get the examination process started, and then they'll go that route. So both of them are viable route. It's not kind of necessarily. One is inherently better or worse than the other is kind of more where you're at along the process and what, what kind of fits your needs the best. Michael Hingson  38:09 But at least there is a process that gives you options, and that's always good. Absolutely, patent laws, I well, I won't say it's straightforward, but given you know, in in our country today, we've got so many different kinds of things going on in the courts and all that, and sometimes one can only shake one's head at some of the decisions that are made regarding politics and all that, but that just seems to be a whole lot more complicated and a lot less straightforward than what you do With patent law? Is that really true? Or are there lots of curves that people bend things to go all sorts of different ways that make life difficult for you? Devin Miller  38:50 Um, probably a little bit of both. I think that it so. The law, legal system in general, is a much more slower moving enemy, so it does have a bit more of a kind of a basis to anticipate where things are headed in general. Now, the exception is, there always is an exception to the rule. Is that anytime the Supreme Court gets involved with patent law cases, I'd say 95% of the time, they make it worse rather than better. So, you know, you get judges that none of them are really have an experience or background in patent law. They've never done it. They really don't have too much familiarity with it, and now they're getting posed questions that are fairly involved in intricate and most of the time when they make decisions, they make it worse. It's less clear. You know, it's not as great of understanding, and it otherwise complicates things more. And so when you get the Supreme Court involved, then they can kind of make it more difficult or kind of shake things up. But by and large, it is a not that there isn't a lot of or involved in going through the process to convince the patent and examiner the patent office of patentability and make sure it's well drafted and has the it's good of coverage and scope, but at least there is, to a degree, that ability to anticipate. Hate, you know what it what's going to be required, or what you may likely to be looking at. You know? The other exception is, is, you know, the, ironically, I think the patent office is the only budget or producing or budget positive entity within all of the government. So every other part of the government spends much more money than they ever make. The Patent Office is, I think the, I think the postal office at one point was the other one, and they have, now are always in the in the red, and never make any money. But, you know, they are the patent office. Now, the problem with that is, you think, great, well now they can reinvest. They can approve, they should have the best technology, they should be the most up to date. They should have, you know, all the resources because they're self funding, and yet, there's always a piggy bank that the government goes to raid and redirects all those funds to other pet projects. And so, or the patent office is always, perpetually underfunded, as ironic as that is, because they're getting, always getting the piggy bank rated, and so with that, you know, they are, if you're to go into a lot of the patent office, their interfaces, their websites or databases, their systems, it feels like you're the onset of the or late 90s, early 2000s as far as everything goes. And so that always is not necessarily your question, but it's always a bit aggravating that you know you can't, as an example, can't submit color drawings. People ask, can you submit videos? Nope, you can't submit any videos of your invention, you know, can you provide, you know, other types of information? Nope, it's really just a written document, and it is line drawings that are black and white, and you can't submit anything beyond that. So there's one where I think eventually it will sometime, maybe shift or change, but it's going to be not anytime soon. I don't think there's any time on the horizon, because they're kind of stuck it once they move, moved over to the lit or initially onto the computer system, that's about where that evolution stopped. Michael Hingson  41:51 Well, the other thing though, with with videos, especially when you get AI involved and so on, are you really seeing a video of the invention. Or are you seeing something that somebody created that looks great, but the invention may not really do it. So I can understand their arguments, but there have to be ways to deal with that stuff. Devin Miller  42:13 Yeah, and I think that even be prior to AI, even we just had, you know, videos been around for 20 or 30 years, even, you know, digital format or longer. That probably, and the problem is, I think it's more of the search ability. So if you have a drawing, you can more easily search drawings and compare them side by side, and they'll do it. If you have a video, you know what? What format is the video? And is it a, you know, dot movie, or dot MOV, or is it.mp for is it color? Is it black and white? How do you capture it? Is it zoomed in as a kind of show all the details? Or is it zoomed out? And I think that there's enough difficulty in comparing video side by side and having a rigid enough or standardized format, the patent office said, man, we're not going to worry about it. Yes, so we could probably figure something out, but that's more work than anybody, any administration or any of the directors of the patent office ever want to tackle so it's just always kind of kicked down the road. Michael Hingson  43:06 Do they ever actually want to see the invention itself? Devin Miller  43:12 Not really, I mean, you so the short answer is no. I mean, they want to see the invention as it's captured within the the patent application. So the problem Michael Hingson  43:21 is, the drawing, they don't want to see the actual device, or whatever it is, well, and a lot Devin Miller  43:24 of times, you know as a inventors, they you know as a patent applicants, as the inventors and the owners, you're saying, hey, but I want to show them the invention. Problem is, the invention doesn't always mirror exactly what's showing in the patent application. Because you're on generation three of your product patent application is still in generation one, yeah, and so it doesn't mirror, and so the examiners are supposed to, they don't always, or aren't always good, and sometimes pull things and they shouldn't, but they're supposed to just consider whatever is conveyed in the patent application. Yeah, it's a closed world. And so bringing those additional things in now you can, so technically, you can request a live in office interview with the examiner, where you sit down live. You can bring in your invention or other or details and information, and when you do it live, face to face with an interview, you can walk them through it. Most very few people attorneys ever do that because one clients aren't going to want to pay for you to one of the offices, put you up in a hotel, you know, sit there, spend a day or two to or with the examiner to walk them through it. It just adds a significant amount of expense. Examiners don't particularly like it, because they have to dedicate significantly more time to doing that. Yeah, they're allotted, so they lose they basically are doing a lot of free work, and then you're pulling in a lot of information that they really can't consider. So you technically can. But I would say that you know, the likelihood of the majority of attorneys, 99 point whatever, percent don't do that, including myself. I've never been to do a live or live one, just because it just doesn't, it doesn't have enough advantage to make it worthwhile. Michael Hingson  44:58 Well, in talking about. About the law and all the things that go on with it. One of the things that comes to mind is, let's say you have somebody in the United States who's patenting, or has made a patent. What happens when it all goes to it gets so popular, or whatever, that now it becomes an international type of thing. You've got, I'm sure, all sorts of laws regarding intellectual property and patents and so on internationally. And how do you get protection internationally for a product? Devin Miller  45:32 File it in each country separately. So, you know, there are people, and I understand the inclinations, hey, I want to get a worldwide or global patent that covers everything in every country. The short answer is, you can't. I mean, technically, you could, if you file a patent into every country separately, nobody, including when I used to work or do work for companies including Intel and Amazon and Red Hat and Ford. They don't have patents in every single country throughout the world because they just don't have enough marketplace. You know, you go to a very small, let's say, South African country that you know, where they just don't sell their product enough in it, it just doesn't make the sense, or the courts or the systems or the patent office isn't well enough to find, or it's not enforceable enough that it just doesn't capture that value. And so there isn't a ability to have a global, worldwide patent, and it really is one where you have to file into each country separately. They each have their own somewhat similar criteria, still a different, somewhat similar process, but they each have their own criteria in their process that has to go through examination. So when you're looking at you know when you want to go for whether it's in the US or any other country, when you're deciding where you want to file it, it's really a matter of what marketplaces you're going to be selling the product into. So if you look at it and you know, I have as an example, some clients that 95% of their marketplace is all in the US, that's where they anticipate, that's probably where they're going to sell it. Well, yes, you could go and find, if you have 2% of your marketplace in Japan, you could go file a patent and get it into Japan, but you have such a small amount of your marketplace that's probably there that it doesn't make sense. And vice versa will have as an example. And a lot of times in the medical devices, they'll a lot of times file both in the EU as well as in the US, because those are two of the predominant medical device and are places where a lot of innovation is going on, where there's a lot of focus on utilization, development, medical devices, and there's just a lot of that demand. And so you're really going to look at it is which, where's your marketplace. The other times are the people, a lot of times, they'll get tripped up on so they'll say, Well, I probably need to file into China, right? And I said, Well, maybe because the inclination is, well, everybody just goes to China. They'll knock off the product. And so I want to have a patent in China so that I can, you know, fight against the knockoffs. And that isn't while I again, understand why they would ask that question. It wouldn't be the right way to convey it. Because if you if all it is is they you have no real, you know, no desire, no plan, to go into China. You're not going to sell it. You're not going to build a business there. If they're knocking it off and just just doing it in China, so to speak, then they're not. There isn't going to be a need to file a patent in China, because you don't have any marketplace in there. There's nothing really to protect. And if somebody makes it in China as a just picking on China, making as an example, and imports it into the US, you can still enforce your patent or otherwise do or utilize it to stop people from importing knock off because it's in the US, because they're, yeah, exactly, they're selling it, importing it, or otherwise doing activities in the US. So it's really a matter of where your marketplace is, not where you think that somebody might knock it off. Or, Hey, I'm gonna get a try and get a global patent, even though my marketplace is really in one or two spots. Michael Hingson  48:38 What about products like, say, the iPhone, which are commonly used all over. Devin Miller  48:44 Yeah, they're going to do, they'll do a lot of countries. They still Michael Hingson  48:47 won't do. They'll still do kind of country by country. Devin Miller  48:50 Yeah, they'll now, they'll do a lot of countries. Don't get me wrong, a lot of right. Phones are sold throughout the world, but they'll still look at it as to where it is, and they still have, you know, issues with them. So one of the interesting tidbits as an example, so going back and rewinding your time, taking apple as an example. You know, they came out with, originally, the iPod, then they had iPhone, and then they had the iPad. Now the question is, when they originally came out with their watch, what did they call it? 49:17 Apple Watch? Apple Watch. Now, why Devin Miller  49:20 didn't they call the I wash, which is what it made sense. It goes right along with the iPhone, the iPad, the iPhone, you know, the all of those iPod on that. And it was because somebody had already got a trademark in China that was for a different company, unrelated to the apple that had it for the iWatch. And so when Apple tried to go into the country, they tried to negotiate. They tried to bully. They weren't able to successfully get the rights or to be able to use I wash within China. China was a big enough market, and so they had and rather than try and split it and call it the I wash everywhere but China and trying to have the Apple Watch in China, they opted to call it the Apple Watch. Now I think they might. Of eventually resolve that, and I think it's now can be referred to as the I watch, I'm not sure, but for, at least for a long period of time, they couldn't. They called it the Apple Watch when they released it, for that reason. So even if you have, you know, a big company and one of the biggest ones in the world, you still have to play by the same rules. And why, you can try and leverage your your size and your wealth and that to get your way, there's still those, there's still those hindrances. So that's kind of maybe a side, a side note, but it's kind of one that's interesting. Michael Hingson  50:30 So that's the trademark of how you name it. But how about the technology itself? When the Apple Watch was created, I'm assuming that they were able to patent that. Devin Miller  50:39 Yeah, they will have, I'm sure they probably have anywhere from 30 to 100 to 200 I mean, they'll have a significant amount of patents, even it's just within the Apple Watch, everything from the screen, the display, how it's waterproof, how it does communications, how does the battery management, how does the touch, how does the interface, all of those are going to be different aspects that they continue to, you know, did it originally in the original Apple Watch, and are always iterating and changing as they continue to improve the technology. So generally, you know that, I'm sure that you will start out with as a business of protecting you're getting a foundational patent where you kind of protect the initial invention, but if it's successful and you're building it out, you're going to continue to file a number of patents to capture those ongoing innovations, and then you're going to file it into all of the countries where you have a reasonable market size that makes it worthwhile to make the investment. Michael Hingson  51:32 So if you have a new company and they've got a name and all that, what should new businesses do in terms of looking and performing a comprehensive search for of trademarks and so on to make sure they are doing the right thing. Devin Miller  51:49 Yeah, a couple of things. I mean, it wanted, if you're it depends on the size of company, your budget, there's always the overlay of, you know, you can want to do everything in the world, and if you don't have the budget, then you have to figure out what goes in your budget. But if I'll take it from kind of a startup or a small business perspective, you know, you first thing you should do is just as stupid and as easy as it sounds, you should go do a Google search. Or, now that you have chat GPT, go do a chat BT search and a Google search. But, you know, because it's interesting as it sounds, or, you know, is you think that, oh, that's, you know, kind of give me or an automatic I'll have still even till today, people come into my office. They'll say, Hey, I've got this great idea, this great invention, and a Lacher getting a patent on it, and they'll start to walk me through it. I'm like, you know, I could have sworn I've seen that before. I've seen something very similar. We'll sit down at my desk, take two minutes, do a Google search, and say, so is this a product that you're thinking of? Oh, yeah, that's exactly it. Okay. Well, you can't really get a patent on something that's already been invented and out there, and so, you know, do a little bit of research yourself. Now there is a double edged sword, because you can do research and sometimes you'll have one or two things happen. You'll not having the experience and background, not entirely knowing what you're doing. You'll do research, and you'll either one say, Hey, I've done a whole bunch of research. I can't really find anything that's similar. When, in fact, there's a lot of similar things out there. There's a patent, and people will say, yeah, it's the same, it's the same invention, but my purpose is a little bit different. Well, you can't if it's the exact same or invention. Whether or not you say your purpose is different, doesn't get around their patent and same thing on a trademark. Yeah, their brand's pretty much 53:20 identical, but they're Devin Miller  53:21 doing legal services and I'm doing legal tools, and so it's different, and it's, again, it's one where there's there they have a false sense of security because they rationalize in their head why it's different, or vice versa. You also get people that will say, Hey, this is even though it's significantly different, it's the same purpose. And so while, while they really could go do the product, while they could get a patent or a trademark, because they think that it's just overall kind of the same concept, then they talk themselves out of it when they don't need to. So I would say, start out doing some of that initial research. I would do it if I was in their shoes, but temper it with, you know, do it as an initial review. If there's something that's identical or the same that's out there, then it gives you an idea. Probably, you know, you're not going to be able to add a minimum, get or patent their intellectual property protection, and you may infringe on someone else's but if you you know, if there's, there's some differences, or have to do that initial research, that's probably the time, if you're serious about, you know, investing or getting business up and going, you've probably engaged an attorney to do a more formal search, where they have the experience in the background and ability to better give a better understanding or determination as to whether or not something presents an issue. Michael Hingson  54:32 Yeah, well, that's understandable. If I've developed something and I have a patent for it, then I suddenly discovered that people are selling knockoffs or other similar devices on places like Amazon and so on. What do you do about that? Because I'm sure there must be a bunch of that that that does go on today. Devin Miller  54:53 Yeah, yes, it does. I mean, I wouldn't say it's not as probably as prevalent as some people think. In other words, not every single. Product, right, being knocked off. Not everything is copied. Sometimes it's because, you know, either I don't have the ability, I don't have the investment, I don't have the, you know, it's not as big enough marketplace, I don't have the manufacturing, I don't have the connections, or it is simply, am respectful, and I'm not going to go do a discord because I'm not going to try and rip off, you know, what I think is someone else's idea. So it doesn't happen that as frequently as I think sometimes people think it does, but it certainly does occur. You know, there's a competitive marketplace, there's a profit incentive, and if there's a good product that's out there that people think they can do something with, and there's a motivation to do it, either because people are unaware that it's an issue, or that they they're unaware that they can't copy it or is protected. And so if you get into that, you know, there's a few potentially different recourses. One is, you know, a lot of times you'll start out with the cease and desist.

You can build more muscle and burn 3x the calories just by changing how you walk. This simple low-impact exercise, rucking, is one of the best ways to improve bone density and overall health without the joint pain of running. In episode 853 of the Savage Perspective Podcast, host Robert Sikes talks with dietitian and rucking expert Kayla Girgen about how to get started with rucking, the best gear to use, and how to avoid common mistakes. They also dive deep into nutrition, explaining how using a continuous glucose monitor (CGM) can reveal the best foods for your body, why a slow-carb diet might be better than keto for some, and simple tricks to manage your blood sugar for steady energy all day.Want to learn the system to build muscle and optimize your own nutrition? Join Robert's FREE Bodybuilding Masterclass to get the tools you need to build your best body. Sign up here: https://www.ketobodybuilding.com/registration-2https://www.instagram.com/kaylagirgenrd/Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters:0:00 - The Ultimate Guide to Rucking & Bio-Hacking Your Nutrition 3:12 - How a Fitness Expert Discovered Rucking 3:37 - The Military Origins and Mental Benefits of Rucking 4:24 - Why Rucking is The Best Exercise for Longevity 5:28 - The #1 Mistake Beginners Make When Rucking 7:20 - How Much Weight Should You Start Rucking With? 8:25 - Is There a Maximum Safe Weight for Rucking? (Military Study) 9:52 - What Is The Best Gear for Rucking? (GoRuck Review) 11:57 - Rucking vs. Walking: What The Data Says About Calorie Burn 13:20 - The Most Important Piece of Rucking Gear You're Ignoring 16:21 - Should You Stop Lifting if You Start Rucking? 18:55 - The Biggest Downside to Rucking 20:33 - A Dietitian's Journey: From Pharmacy to Functional Nutrition 25:14 - The "Slow Carb" Diet: A Dietitian's Simple Framework for Fat Loss 28:02 - Why Modern Society Has a Broken Relationship With Food 33:29 - How to Use a CGM to Find Your Perfect Diet 36:30 - Are CGMs a Waste of Time for Healthy People? 40:09 - What is the Best Continuous Glucose Monitor (CGM)? 42:21 - How to Lower Your Blood Sugar After a Meal (3 Simple Tricks) 44:12 - The Dangers of "Flatlining" Your Blood Sugar 47:00 - The Hidden Meaning Behind Your Blood Sugar Spikes 48:44 - Should You Go Keto or Carnivore? 50:51 - How to Eat Carbs Without Spiking Your Blood Sugar 54:44 - Do You Really Need to Eat Fiber on a Low-Carb Diet? 58:07 - The Psychological Trick to Sticking With Any Diet 1:00:01 - A Mindset Shift to Optimize Your Health: Stop Asking "What Can I Get Away With?" 1:04:53 - Where to Find Kayla Girgen & Her Book "RuckFit"

Amazon's AI Doctor Is Live. The Health Tech War Begins! It uses large language models trained on your medical records to: Answer health questions Manage prescriptions Coordinate care. So should we be delighted or terrified? Also today.... ☕ Dunkin Donuts vs CGM experiment

Send us a textHello and welcome to Charles George Missions and CGM Presents: In the Word. My name is Dr. Stephanie Wright. This is Episode 2, ABC to PhD. Thank you for joining us today. We encourage you to listen to Episode 1, of this series if you are joining us for the first time.The resource for this series will be the book Spiritual Warfare Manual ABC to PhD, written by yours truly, Dr. Stephanie V. Wright. Last week, we shared why this book is relevant to the theme of spiritual warfare. This week, we are going to explain what the ABC to PhD in the book's title stands for and why we should not be intimidated by the term “spiritual warfare.”In each episode, we will read portions from selected chapters in the book. We will not be reading the entire book.Let's go to our reading for today, Chapter 2, Spiritual Warfare Manual: ABC to PhD, pages 25 to 28.*****************************************************************************If you would like to participate in this podcast and share your thoughts on the book, please visit our website at www.cgmissions.com and complete the contact form. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In today's episode, I sit down with Danielle, who shares a powerful and vulnerable story about how false low readings from her CGM led to extreme anxiety, an ER visit, and a complete shift in how she now approaches diabetes management.Danielle walks us through a terrifying day where her CGM repeatedly showed dangerously low glucose readings—despite her body showing no symptoms and fingerstick checks telling a different story. The constant alarms, conflicting data, and uncertainty triggered intense anxiety and ultimately landed her in the hospital, where she was treated as if she were hypoglycemic even though lab results showed otherwise.

CGMs and GLP-1s are everywhere right now, but should everyone be using them? In this episode, Andrew Wade, registered dietitian and CEO of Case Specific Nutrition, is joined by Brad and Hillary, both registered dietitians and lead clinicians at their own offices, to break down the most common question they hear in practice: should non-diabetics get a CGM to improve their health? Together, they explore how to interpret CGM data, the risks of chasing numbers without context, and what happens when "optimization" replaces foundational health behaviors. The conversation also covers the growing role of GLP-1 medications, recent updates around accessibility and pricing, and why cost reductions can be both a promising step forward and a potential risk depending on how these medications are used. Brad and Hillary react to the explosion of GLP-1 content on social media, including patches, supplements, and "natural" protocols, and unpack ingredient obsessions like probiotics and Akkermansia. Through real client stories, they challenge weight loss expectations, highlight why eating more, building muscle, and fueling adequately can sometimes drive better results, and reinforce a core message from clinical practice: GLP-1s without lifestyle change are not the shortcut people hope they will be.

In this episode of Keeping it 100 Radio, I'm finally sharing my full birth and labor experience as someone living with type 1 diabetes - six months postpartum and completely unfiltered.I'm joined by Val for an honest conversation about induction, blood sugar management during labor, and the fear-based narratives that often surround pregnancy with diabetes. I walk through what actually happened on induction day, why I chose to be induced, how I managed my pump and CGM in the hospital, and what surprised me most about labor, delivery, and the immediate postpartum period.We talk about:The difference between spontaneous labor, induction, and C-sectionsThe “big baby” myth in type 1 diabetesTrusting your care team without feeling bulliedManaging blood sugars during labor and after deliveryWhat labor really felt likeThe emotional and physical shift after your baby arrivesIf you're pregnant with type 1 diabetes, planning to be, or feeling overwhelmed by scary stories online, this episode is for you. This is a real, positive, and empowering look at birth with diabetes.. no sugarcoating, no fear tactics, just my experience.Grab the T1D Pregnancy Checklist (for FREE) here: https://needlesandspoons.com/pregnancy-checklist-optin

Paul Goode, President and CEO of Glucotrack, discusses the evolution and future of continuous glucose and continuous blood glucose monitoring for people with diabetes, as well as opportunities for implantable CMG monitors. In addition to convenience and comfort, the Glucotrack implantable CGM monitor is designed to be more accurate and measure blood glucose. This approach eliminates the lag time associated with wearable CGMs that measure interstitial fluid, enabling faster, more effective treatment decisions.   Paul explains, "When you look at the market penetration of CGM in the US, even for those who are covered with insurance, because it is a standard of care in a large portion of patients with diabetes, it's still only a little over 50%. And when you try to understand why, it's because the technology works well, it's pretty accurate, and it helps patients. Market research shows that it's a collection of various reasons."   "When we realized that a large majority of the problems with use of current CGMs, whether people are using them, or people don't want to use them, a lot of these, let's call them hassle factors or discomfort factors, were because it was a wearable product. So we said, well, let's go inside the body, and that resolves almost all of those types of problems."   "Then we said, well, if we're in the body, we can also measure the glucose that's in the blood, actually measure blood glucose. Most folks don't realize that many do, but many don't, that CGM, the wearable CGMs, measure the interstitial fluid and not the actual blood glucose. And typically that's not a problem. There is a time lag between blood glucose and interstitial fluid, with interstitial fluid lagging behind anywhere from 10 to 20 minutes. But that's usually only a problem during rapid rates of change, for example, when one is eating, exercising, or sick. " #Glucotrack #DiabetesTech #MedicalDevices #ContinuousGlucoseMonitoring #HealthcareInnovation #DiabetesManagement #ImplantableTech #BloodGlucose #CGM #MedTech #DiabetesCare #HealthTech glucotrack.com Download the transcript here

Paul Goode, President and CEO of Glucotrack, discusses the evolution and future of continuous glucose and continuous blood glucose monitoring for people with diabetes, as well as opportunities for implantable CMG monitors. In addition to convenience and comfort, the Glucotrack implantable CGM monitor is designed to be more accurate and measure blood glucose. This approach eliminates the lag time associated with wearable CGMs that measure interstitial fluid, enabling faster, more effective treatment decisions.   Paul explains, "When you look at the market penetration of CGM in the US, even for those who are covered with insurance, because it is a standard of care in a large portion of patients with diabetes, it's still only a little over 50%. And when you try to understand why, it's because the technology works well, it's pretty accurate, and it helps patients. Market research shows that it's a collection of various reasons."   "When we realized that a large majority of the problems with use of current CGMs, whether people are using them, or people don't want to use them, a lot of these, let's call them hassle factors or discomfort factors, were because it was a wearable product. So we said, well, let's go inside the body, and that resolves almost all of those types of problems."   "Then we said, well, if we're in the body, we can also measure the glucose that's in the blood, actually measure blood glucose. Most folks don't realize that many do, but many don't, that CGM, the wearable CGMs, measure the interstitial fluid and not the actual blood glucose. And typically that's not a problem. There is a time lag between blood glucose and interstitial fluid, with interstitial fluid lagging behind anywhere from 10 to 20 minutes. But that's usually only a problem during rapid rates of change, for example, when one is eating, exercising, or sick. " #Glucotrack #DiabetesTech #MedicalDevices #ContinuousGlucoseMonitoring #HealthcareInnovation #DiabetesManagement #ImplantableTech #BloodGlucose #CGM #MedTech #DiabetesCare #HealthTech glucotrack.com Listen to the podcast here

Send us a textHello and welcome to a new podcast year for Charles George Missions', CGM Presents: In the Word. My name is Dr. Stephanie Wright, and on behalf of Dr. Charles Wright and the Board of Directors of CGM, Happy New Year, and thank you for your support last year.This year's podcast is entitled “Spiritual Warfare,” and the resource for this topic will be the book Spiritual Warfare Manual: ABC to PhD, written by yours truly, Dr. Stephanie V. Wright. This book is relevant to the theme of spiritual warfare because it is based on my more than 50 years of experience and on Dr. Charles Wright's more than 50 years of experience in this area. This book discusses the following topics on spiritual warfare: What is Spiritual Warfare?, Victory Through Christ, The Role of the Holy Spirit, Practical Tools for Warfare, Understanding the Enemy (Satan) and his tactics, Overcoming Fear, Personal Growth, The Power of God's Word, and the Spiritual Rewards from Spiritual Warfare.All of these are relevant to the podcast's purpose: “to equip you for strategic spiritual warfare.”Let's jump right in to Chapter 1, “His Covering,” where we will define spiritual warfare and a few of its attributes..If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Episode 4 of Doing Well with Diabetes Season 2 features Kerry Murphy, wife and mother to multiple people with type 1 diabetes and founder of Follow T1Ds, who explains how her long, layered exposure to T1D—from her sister-in-law and husband to her niece and daughter—pushed her from terrified observer to frontline advocate. She describes the collision between modern diabetes tech (CGMs, pumps, data-driven care) and school systems still operating on 1990s protocols, culminating in nurses refusing to follow CGM data during the school day.  After discovering Department of Justice rulings that treating CGM follow as a reasonable ADA accommodation applies nationwide, she built Follow T1Ds around three demands: follow T1D CGMs, follow parent input, and follow federal law. The conversation covers how parents can move from raw fear and frustration to strategic advocacy, why labeling kids “non-compliant” ignores context and equity, and why school nurses are often the only line of real safety for some students. Kerry's long-term aim is systems change so that parents don't have to become de facto lawyers and policy experts just to keep their kids safe at school. Chapters 00:40 – Kerry Murphy and Follow T1Ds 01:47 – Kerry's Deep Family History With Type 1 Diabetes 04:58 – Screening Her Sons, Avoiding DKA, and Early Symptom Hindsight 08:32 – Watching From the Sidelines, Then Becoming a Caregiver Herself 09:38 – Kindergarten Clash: Modern Tech vs 1990s School Protocols 14:27 – DOJ/ADA Rulings and the Three Pillars of Follow T1Ds 23:22 – How Parents Navigate Fear, Gaslighting, and Hard Conversations With Schools 30:32 – “Non-Compliant” Kids, Equity, and Why School Nurses Must Step Up 38:21 – Long-Term Vision: Systems Change So Parents Don't Have to Be Lawyers Resources: https://followt1ds.org/ Kerry's Instagram

Other Episodes You Might Like: Previous Episode - Why Your Daily Workouts Are Making You Weaker After 50 Next Episode - What 40+ Studies Reveal About Rep-Range for Muscle, Strength, and Bone After 50 More Like This - 10 Things We Learned from Wearing a CGM, So You Don't Have To Resources: Don't know where to start? Book your Discovery Call with Debra. Leave this session with insight into exactly what to do right now to make small changes, smart decisions about your exercise time and energy. My favorite Blood Glucose Monitor here! Analyze in real-time how your body responds to food, exercise, stress, and sleep. You can't fix your blood sugar if you don't know you have a blood sugar problem.  A large percent of women are unaware they have prediabetes and in this episode we point out just how to see early signs, what options for treatment and lifestyle changes help, and hear some case studies that you can identify with.  You can fix your blood sugar and it's not an overwhelming task. Join us for this episode and take a deeper dive with the book.  My Guest: Dr. Beverly Yates ND is on a mission to help 3 Million people heal from type 2 diabetes and prediabetes. She has helped thousands of people reverse Type 2 Diabetes and Prediabetes, and now has a telehealth practice. Dr. Yates is an MIT engineer, a Naturopathic physician, and the author of a new book whose publication date is January 20, 2026.  The title is: The Yates Protocol: 5 Simple Steps To Fix Your Blood Sugar & Reverse Type 2 Diabetes. The subtitle is: Make Peace With Food and Never Feel Deprived Again. This book is in the pre-order phase, and is published by the Avery imprint of Penguin Random House. Her prior career as an MIT engineer helps her use health data and people's specific health goals to create practical, sustainable habits that help people heal from metabolic damage, and reverse type 2 diabetes and prediabetes. Questions We Answer in This Episode: [00:02:45] Are taking meds the only answer to dealing with blood sugar issues? Are they still the first thing prescribed?  [00:06:37] Your “take” on CGM use? Is “knowing” from CGM enough… or do we still resist change?  [00:10:20] Does family history of diabetes predetermine personal risk? Is a person doomed if there is a family history of type 2 diabetes or prediabetes? [00:15:09] What is the Yates Protocol and what struck you to create this?  [00:20:18] What and where can we get the secret chapter of your book, The Yates Protocol?

In this episode of The Huddle: Conversations with the Diabetes Care Team, Jami Klein RN, CDCES, Senior Manager of Clinical Education at Dexcom, joins Davida Kruger, MSN, APN-BC, BC-ADM, Certified Nurse Practitioner at Henry Ford Health System, for a practical conversation on integrating continuous glucose monitoring into primary care. Together, they explore Dexcom's CGM clinic workflow toolkit, highlighting how nurse practitioners and DCESs can streamline implementation, improve efficiency, and empower patients through data-driven care. This episode was supported by Dexcom. You can view Dexcom's CGM workflow by visiting dexcom.com/clinical-workflow. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast. Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Metabolic health impacts far more than weight — it influences your hormones, inflammation levels, energy, and long-term risk for chronic disease. In this episode of Get Well Better by The Lanby, Taylor Fazio, Wellness Advisor, breaks down what metabolic health really means, why most Americans are metabolically unhealthy, and the everyday habits that can dramatically improve insulin sensitivity and overall health.On this “One Take on One Take” episode:Tip 1: Optimize nutrition by prioritizing fiber, reducing ultra-processed foods, and building balanced meals to support stable blood sugar and reduce inflammation.Tip 2: Build movement into your day — especially strength training — since muscle is one of the most important sites for glucose storage and insulin sensitivity.Tip 3: Use data to personalize your health journey: track key labs (fasting insulin, glucose, HbA1c) and consider a CGM to understand your unique glucose response and improve metabolic flexibility.

Kellie is a strategic business mentor who bulldozed through three autoimmune conditions—until her body forced a reckoning.In this conversation, she breaks down how a £50 glucose monitor revealed the root cause behind years of debilitating crashes (spoiler: it wasn't burnout), why her injury rehab degree couldn't save her from herself, and the exact protocol that dropped her rheumatoid factor from >150 to 50.No woo. No "listen to your body" platitudes. Just the tactical breakdown of what actually worked when rest wasn't optional anymore.What we cover:Why competitive people fail at "gentle yoga" (and what works instead)The CGM data that changed everything: blood sugar dropping to 1.3 after carbsHow she stabilized autoimmune markers, lost 6.5kg, and got off pain medsThe coaching approach that works for headstrong women who hate being told what to doIf you're a high-performer white-knuckling your health while your body keeps the score, this one's for you.To find out how to work with Kellie: Kellies Website Kellies Social Media

Blood sugar impacts far more than diabetes—and for women, it directly affects hormones, metabolism, energy, mood, sleep, and weight regulation.In this episode of Confidently Balance Your Hormones, functional health practitioner Dee Davidson, FDN-P, sits down with Boris Berjan, co-founder of Theia, to explore why Continuous Glucose Monitors (CGMs) are becoming a game-changing tool for women's health.We dive into:Why blood sugar dysregulation is often the missing link in hormone imbalanceHow CGMs provide real-time insight into metabolism—not just food reactionsWhy stress, sleep, emotions, and fasting can spike glucose (even with “perfect” diets)How women can use CGM data to support cycle syncing, energy, and hormone balanceWhy Theia goes beyond numbers to create clear, actionable daily scoresIf you've ever wondered why you're doing “all the right things” but still feel tired, wired, or stuck—this conversation will give you clarity.

What if the biggest breakthrough in weight management is not a new diet, but finally seeing how your body responds in real time? That question sat at the center of my conversation with Sharam Fouladgar-Mercer, CEO and co-founder of Signos, a continuous glucose monitoring (CGM) and AI-powered health platform built to help people manage weight by understanding their metabolism. January is when motivation is high and the wellness noise is loud, but it is also when a lot of people realize how hard it is to stick with generic advice that does not fit real life. This episode is about why personalization matters, how metabolic signals can change the way you think about food and exercise, and what happens when health technology shifts from reporting the past to guiding the next decision. Sharam explained how Signos pairs a CGM with an AI-driven experience that turns glucose data into practical actions. The point is not to force people into rigid rules or extreme restrictions. Instead, it is about learning how your body reacts to everyday choices, then using that feedback to reduce spikes, improve consistency, and build habits you can actually live with. We talked about simple interventions, like changing the order of foods in a meal, timing movement more intelligently, and spotting patterns that would otherwise stay invisible. Two personal stories brought the conversation to life. Sharam shared how he lost 25 pounds while increasing his calorie intake, which challenges a lot of assumptions people carry into weight loss. He also shared a story from his family life, where his wife's deep sleep increased from roughly 20 minutes a night to around 60 minutes after focusing on glucose stability, even while total sleep time remained limited during the intense period of raising young kids. It is the kind of detail that hits home for anyone who has ever tried to make healthier choices while exhausted and stretched thin. We also explored why FDA clearance matters for Signos and what that could mean for mainstream access. Over-the-counter availability reduces friction, can lower cost, and opens the door to broader adoption, including potential FSA and HSA eligibility. Looking ahead, Sharam shared a vision that goes beyond weight management, connecting metabolic health to the long arc of prevention and chronic conditions where insulin resistance plays a role. If you have ever felt like you are doing all the "right" things and still not seeing results, this episode will make you rethink what "right" even means. And if you could finally see your metabolism in real time, would it change how you approach food, sleep, exercise, and the habits you want to keep this year? Useful Links Connect with Sharam Fouladgar-Mercer Learn more about Signos Instagram, Facebook, X and YouTube Thanks to our sponsors, Alcor, for supporting the show.  

Born into the Unification Church, Laurel candidly discusses growing up in a cult, mass weddings, and why she eventually left to protect her children. This is Part 1 of 2. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. 

Back in 2024 with Calley Means at South by Southwest, we sat down and talked about his mission to flip the old American food pyramid upside down for the greater good. Well guess what, the pressure is finally working! This rerun is the ultimate receipt that focus, repetition, and smart lobbying for human health can still move the needle! Host Dave Asprey sits down with Calley Means, entrepreneur, policy advocate, and co-author of Good Energy. Together, they break down how the U.S. healthcare system became a sick-care system, why ultra-processed food dominates public policy, and how individuals can reclaim autonomy over their biology. From CGMs and metabolic health to food subsidies, lobbying, and free speech, this episode challenges deeply held assumptions about medicine, nutrition, and personal responsibility.You'll Learn: • Why chronic disease is the most profitable business model in modern history • How metabolic dysfunction drives obesity, diabetes, depression, and infertility • Why ultra-processed food sits at the root of America's health collapse • How CGMs and metabolic data threaten entrenched healthcare incentives • What “food is medicine” really means and where it gets weaponized • How HSA and FSA dollars can legally support food, exercise, and prevention • Why fixing incentives matters more than blaming individuals • How reclaiming health autonomy is tied to free speech and human resilience Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast for people who want to take control of their biology, extend their longevity, and optimize every system in the body and mind. Each episode features cutting-edge insights in health, performance, neuroscience, supplements, nutrition, hacking, emotional intelligence, and conscious living. Episodes are released every Tuesday, Thursday, and Friday (audio-only) where Dave asks the questions no one else dares, and brings you real tools to become more resilient, aware, and high performing. Keywords: Calley Means Good Energy, Calley Means interview, Good Energy metabolic health, metabolic dysfunction America, ultra processed food policy, food is medicine debate, healthcare incentives crisis, chronic disease economics, insulin resistance epidemic, CGM health data access, metabolic health lobbying, seed oils sugar inflammation, glyphosate food system, HSA food exercise eligibility, health autonomy biohacking, metabolic freedom podcast, american food pyramid, rfk food pyramid, 2026 food pyramid Thank you to our sponsors! Essentia | Go to https://myessentia.com/dave and use code DAVE for $100 off The Dave Asprey Upgrade. Resources: • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Join My Low-Oxalate 30-Day Challenge: https://daveasprey.com/2026-low-ox-reset/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 – Introduction 2:11 – Mom's Cancer Story 4:24 – Healthcare System Incentives 10:14 – TruMed and Food as Medicine 15:51 – FDA and IRS Pushback 17:25 – Political Solutions and RFK 19:49 – Childhood Obesity Crisis 21:49 – The Chronic Disease Industry 26:54 – State of Emergency Proposal 29:07 – Healthcare Industry Mindset 31:30 – COVID and Metabolic Health 32:28 – Taking Back Health Autonomy 34:16 – Medical System Collusion 35:56 – Research Corruption 37:21 – Pharma Bribes and Conflicts 40:17 – Ozempic and Civil Rights Groups 42:35 – Personal Mission and Mom's Legacy 50:16 – Media Power and Free Speech 54:00 – Weaponizing Social Justice 55:16 – Systemic Poisoning of the Population 57:37 – Technology as a Health Solution 1:03:20 – Regenerative Farming and Robotics 1:06:34 – Controlling the Food Supply 1:10:18 – Closing Thoughts See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textDr. Heather Stone is a returning guest on our show! Be sure to check out her first appearance on episode 833 of BBR!Dr. Heather Stone, DC is one of the most successful functional medicine practitioners in the world. She has spent the last twenty-one years helping patients reverse various chronic diseases. Her focus is on helping women return to the person they know themselves to be by experiencing a total thyroid transformation. She is passionate about health, longevity, gardening, cooking, regenerative farming, and raising her animals on her ranch.Dr. Heather also currently runs two functional medicine clinics, as well as Born To Heal Ranch & Retreat, which is a functional medicine retreat center for women dealing with hypothyroidism and Hashimoto's.Throughout her career, Dr. Heather has been instrumental in showing tens of thousands of patients how to reverse long-standing health problems with a focus on type 2 diabetes, hypothyroidism, and cognitive decline. She is also the author of her amazing book Thyroid Transformation Blueprint.Dr. Heather is married and has two sons, Cam and Cannon, and currently lives on her ranch in Texas with her family and two dogs. When she is not working, she is reading, meditating, cooking, or traveling the world.Find Dr. Heather at-https://reversemycondition.com/FB Page- Happy, Healthy and Lean- Women Overcoming Low Thyroid!IG- @drheatherstonehttps://www.borntohealranchandretreat.com/Find Boundless Body at- myboundlessbody.com Book a session with us here!

Subscribe to our channel:    / @optispan  Get Our Newsletter (It's Free): https://www.optispan.life/Join Matt and Dr. Nicole (Nicki) Byrne, Clinic Director at Optispan, for a deep dive into preventative Healthspan Medicine. In this episode, they discuss why traditional reactive healthcare is failing us, what true preventative care looks like, and the comprehensive, data-driven approach used at Optispan to catch risks early and optimize long-term health. From advanced diagnostics to lifestyle pillars and evidence-based medications, learn how to shift from treating disease to building resilience.

On this episode of Danatech Talks–a special series from The Huddle– Paola Acevedo, PharmD, CDCES, walks through how to simplify the process of prescribing diabetes technology. Paola discusses common pain points both clients and prescribers may face related to documentation, coverage and affordability, and accessibility. She also shares practical strategies, systems and workflows providers and practices can implement to help navigate through these potential challenges.This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsExplore danatech's technology affordability tool: Diabetes Technology Affordability OptionsListen to previous episodes of our Danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionalshttps://thehuddle.simplecast.com/episodes/understanding-cgms-and-interpreting-data-for-beginners  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast episode, the host welcomes Kayla Girgen, a dietitian and author of "Ruck Fit," a book focused on rucking. They discuss Kayla's background, inspiration for the book, and the benefits of rucking, citing personal anecdotes and experiences. The conversation covers Kayla's journey from academic endeavors to her passion for fitness and nutrition, eventually leading to her own business. They highlight the physical and mental benefits of rucking, the importance of proper gear, and strategies for getting started. Additional topics include blood sugar management, the impact of sleep on health, and the flexibility of intermittent fasting. Kayla also shares information about her CGM program and an upcoming rucking challenge in collaboration with GORUCK. The episode emphasizes practical advice for initiating and maintaining a healthy lifestyle.   Kayla Girgen is a certified personal trainer and licensed dietitian who specializes in weight management, metabolism support, and sustainable habit change. She completed her supervised practice at the Mayo Clinic and works at the intersection of fitness and nutrition.   FULL TEMPLE RESET registration is now open. Check it out here: https://kingsbu.com/fulltemplereset The Community is coming! Click here to learn more   Connect with Kayla here: Instagram: @kaylagirgenrd Ruck Fit   Connect with Kyle: I'm back on Instagram, come say hey @kylekingsbu Twitter: @kingsbu Our Farm Initiative: @gardenersofeden.earth Odysee: odysee.com/@KyleKingsburypod Youtube: https://www.youtube.com/@Kyle-Kingsbury Kyle's Website: www.kingsbu.com - Gardeners of Eden site   If you enjoyed this podcast, please subscribe & leave a 5-star review with your thoughts!

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this today's episode, I sit down with Aurelian, CEO and co-founder of SNAQ, a mobile app designed to make meals less guesswork for people living with Type 1 diabetes.SNAQ was born out of lived experience. Aurelian's wife was diagnosed with T1D over a decade ago, and like many people with diabetes, she constantly faced the same daily questions:How many carbs are in this meal?How heavy is this portion?How will this food affect my blood sugar later?From that frustration came the idea behind SNAQ — an app that allows users to take a photo of their food, estimate carbs and macronutrients, and connect meals directly to CGM, insulin, and activity data to uncover real-world patterns.

What are your thoughts on Alpha-ketoglutarate for healthy aging?A treatment for warts?Am I destined to develop diabetes given my strong family history of diabetes and high blood pressure?

Consequences of weight loss with weight loss drugs...Enter myostatin inhibitor drugsMy latest HgbA1c is 5.9, and I'm doing everything right. What gives?I'm approaching 80. Could you discuss aging?

Send us a textKayla Girgen, RD, LD, CPT, is a registered dietitian, certified personal trainer, and founder of Sugar + Strength Academy—an online wellness community helping women balance blood sugar and build strength, one step at a time.She blends real-life tools like continuous glucose monitoring and accessible movement like rucking to help clients break free from diet extremes and feel strong—both physically and mentally. Kayla's approach centers on progress over perfection and creating results that work in real life.Her upcoming book Ruck Fit: Build Strength and Endurance by Walking with Weight shares how rucking became a catalyst for reclaiming her physical and mental health, proving that fitness doesn't have to be complicated to be life-changing. Her book helps readers understand how to get started, with basic guidelines for beginners, answers to common questions, safety tips, and more advanced strategies to help maximize fitness goals.It surveys gear and gadgets, including packs, plates, footwear, and more, and offers sample training plans designed to put readers on the road to better mobility, greater aerobic fitness, strength, and even competitive challenges.Find Kayla at-https://kaylagirgenrd.com/IG- @kaylagirgenrdYT- @kaylagirgenrdAmazon- Ruck Fit: Build Strength and Endurance by Walking with WeightFind Boundless Body at- myboundlessbody.com Book a session with us here!

This is such a great episode! Today I'm interviewing Bev Mazza, BSN, RN, NC-BC. Bev is a Registered Nurse and Board-Certified Nurse Coach who specializes in metabolic health for women in midlife. She works with women navigating prediabetes, insulin resistance, weight changes, and the hormonal shifts of perimenopause and menopause. Bev combines functional medicine, personalized nutrition, and CGM interpretation to help women get real answers about what's happening in their bodies.  If you are in midlife and struggling with blood sugar issues, this episode is a must-listen.  -Rachel Connect with Bev:  @purelypresenthealth hello@purelypresenthealth.com https://purelypresenthealth.com The Complete Prediabetes Checklist: 10 Steps to Lower Blood Sugar for Women in Perimenopause. These 10 steps are practical, proven, and designed to cut through the confusion and get you moving toward real results.

A funny, honest conversation with 13-year-old Trey and his mom Stephanie about type 1 diabetes, sports, growing up, parenting, pre-bolusing, and why runny eggs somehow matter. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

This episode covers: • Trump Drug Pricing Deals and Access to Longevity Medications New drug-pricing agreements announced under President Donald Trump aim to lower the cost of high-priced prescription drugs through negotiated rebates and pricing pressure on major pharmaceutical companies. Early reporting suggests these changes could affect cardiometabolic and longevity-relevant medications, including GLP-1 diabetes and obesity drugs. Dave explains why the real question is not headline savings, but whether lower prices actually reach patients at the pharmacy counter. He breaks down how affordability shapes real-world access, adherence, and long-term prevention strategies, and why policy decisions can matter more than new mechanisms when it comes to sustainable longevity care. Source: https://longevity.technology/news/trump-sets-new-drug-pricing-deals-with-big-pharma/ • 5:2 Intermittent Fasting Outperforms Daily Dieting on Metabolic Health A controlled study compared three popular strategies in people with obesity and type 2 diabetes: 5:2 intermittent fasting, time-restricted eating, and continuous daily calorie restriction. All approaches improved weight and HbA1c, but the 5:2 protocol produced larger reductions in fasting glucose, triglycerides, and insulin resistance. Dave explains why periodic restriction can outperform constant dieting, how to structure fasting days without tanking performance, and how to pair intermittent fasting with CGM data and training schedules for better metabolic flexibility and long-term health. Source: https://www.sciencedaily.com/releases/2025/07/250715043351.htm Full paper: https://www.nature.com/articles/s41598-025-32673-9 • Cocoa's Theobromine Linked to Slower Epigenetic Aging New research highlighted by Aging-US suggests that theobromine, a bioactive compound found in cocoa, is associated with epigenetic markers of slower biological aging. Dave breaks down what epigenetic aging clocks actually measure, why this finding adds credibility to cocoa's cardiometabolic benefits, and why most chocolate products cancel out the upside with sugar and ultra-processing. He explains how to think about food-derived bioactives without turning them into hype-driven anti-aging shortcuts. Source: https://www.aging-us.com/news-room/theobromine-from-cocoa-linked-to-slower-biological-aging • Organ-Specific Biological Age Clocks Predict Disease Risk More Accurately A large Nature study built biological aging clocks for individual organs using blood-based proteomics, showing that organ-specific aging predicts disease and mortality better than a single “bio age” number. Dave explains why you can be biologically young overall but still have an aging brain, arteries, or kidneys, and how this reframes longevity from generic anti-aging to targeted organ protection. He explores how sleep, blood pressure, glucose control, and exercise map differently to different organs, and why precision aging metrics are the future of prevention. Source: https://www.nature.com/articles/s43587-025-01016-8 • Copper Peptides and the Rise of Skin Longevity Copper peptides like GHK-Cu are moving from niche skincare into serious longevity conversations. Human data show strong effects on collagen synthesis, barrier repair, and wound healing, in some cases outperforming traditional retinoids. Dave explains why skin is not just cosmetic but a key immune and environmental interface, how copper peptides fit into repair-focused protocols, and why cycling repair and stress mirrors smarter approaches to training and recovery across the body. Source: https://www.vogue.com/article/copper-peptides Auro Wellness Copper Peptide with Discount (click on skincare and scroll to Copper Peptide): https://aurowellness.com/pages/dave All source links provided for direct access to the original research and reporting. This episode is designed for biohackers, longevity seekers, and high-performance listeners who want practical strategies grounded in real science and real-world constraints. Dave Asprey translates emerging research, policy shifts, and clinical data into actionable upgrades for metabolism, fasting, biological age tracking, skin health, and long-term prevention. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: Trump drug pricing deals, prescription drug affordability, GLP-1 access, cardiometabolic medications, longevity policy, intermittent fasting 5:2, intermittent energy restriction, time restricted eating study, insulin sensitivity improvement, metabolic flexibility fasting, theobromine cocoa aging, epigenetic aging markers, biological age clocks, organ specific aging, proteomics longevity research, brain age dementia risk, vascular aging, copper peptides GHK-Cu, skin longevity protocols, collagen synthesis skincare, evidence-based biohacking news, longevity science updates Thank you to our sponsors! - HeartMath | Go to https://www.heartmath.com/dave to save 15% off. -Generation Lab | Go to http://generationlab.com/, use code Dave20 for $20 off, and see what your body's really doing behind the surface. Resources: • Subscribe to my weekly newsletter: https://substack.daveasprey.com/welcome • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 - Trailer0:19 - Story 1: Trump's Drug Price Deals 2:33 - Story 2: Fasting Reality Check 4:35 - Story 3: Chocolate and Biological Age 6:11 - Substack Update7:30 - Story 4: Organ-Specific Aging 9:05 - Story 5: Copper Peptides for Skin 11:02 - Weekly Wrap-Up See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They're passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We'll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look like. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Orange BioMed here Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com    Episode transcript:   Stacey Simms  00:05 Today on diabetes connections, making the case for a better at home A1C test. Orange biomed is developing a compact, one drop device that they say could make frequent A1C checks easier and more accessible. They're sharing research that four A1C tests a year can lead to a nearly 4% reduction in A1C levels, but they say a lot of people can't get to the clinic that much. We'll talk about why this matters, even in the era of CGM, how the device works and what the early clinical trial results look like.   This podcast is not intended as medical advice. If you have those kinds of questions, please contact your healthcare provider.   Welcome to a bonus episode of diabetes connections. I hope your December is going well and that you know somehow you're able to take some time for yourself in the middle of all the holiday rushing around this time of year can be magical and stressful and exhausting and wonderful, and you know, all the things. And it's the same thing over here, super busy getting all this stuff done before the end of the year. Love it. But, you know, getting podcast episodes out, writing all the things we write and planning for next year, as they say, We're staying booked and busy.   But quick behind the scenes here to better explain this episode, I taped this interview way back over the summer during the ADA Scientific Sessions conference. I had some technical problems. I actually thought I lost this interview. There were two interviews that seemed to have gone missing. We're going to air the other one very soon. But thankfully, I do have backups upon backups. So all the info that you're going to hear today is still relevant.   This product, a small A1C test, is still in development. The only dated bit is about their follow up event that took place in August. Orange Biomed was launched in 2021 in South Korea, with its US headquarters in Providence, Rhode Island. Its founders are two Duke University alums, and they're my guests, CEO Yeaseul Park and Co-President Unghyeon Ko, We are also joined by Janice Dru-Bennett. She is a senior advisor at the company. Now, English is not the first language of two of these three speakers. This is a good time to remind you that most podcasting platforms have pretty good transcription services these days, especially Apple, I think they have a fantastic real time transcription service for podcasts that has been impressive to me in how they translate diabetes language. They're getting better at it. But I am also going to put a transcript of the interview in the show notes, which I don't normally do because the podcast services have gotten so good at it, but I think it could be helpful for at least a few of you out there. Okay, here is my conversation from the floor of ADA from the team at Orange biomed.   Yeaseul Park, Janice Drew Bennett and Dr Ko, Welcome to diabetes connections. I can't say live from ADA, because we're taping this to air later, but you're all there. Thank you so much for joining   Yeaseul Park  03:08 me. Yes, thank you. We're   03:10 excited to be here. Oh   Stacey Simms  03:11 my goodness. Can I ask first, how is the trip? I mean, yes, let me ask you. You guys came a long way.   Yeaseul Park  03:17 Yeah, it was 13 hours from Korea. But it's I'm so excited, because this event is really one of the times, and this is actually our third time attending ADA.   Stacey Simms  03:31 That's great. And we have so many questions for you, but Janice, let me ask you, you're there as everybody's setting up at the kind of beginnings of the show. What is it like right now for people who aren't familiar with ADA,   Janice Dru-Bennett  03:42 yes, you can hear the hammers in the background, although, but not on this podcast, but there's a lot of noise and people walking by. We're just setting up this the day before the exhibit hall opens and Dr Cole will be presenting at the Innovation Hub tomorrow, which is where we're sitting right now, with tables of innovators will be showcasing their diabetes innovations, and   Stacey Simms  04:04 there's a lot to get to. Dr Koh, I know you're presenting, but yes, let me ask you, like, what why? I know you said it's your third year, but why is orange biomed at ADA, what is your goal   Yeaseul Park  04:16 for us? ADA, is for a learning experience. As well as a platform to share. We come to see how all those around the world are fighting against diabetes, whether through clinical research, digital tools or technologies or community programs. At the same time, you're so proud to hear what orange biomat is building anytime, and eight months exhausting. That makes diabetes monitoring not accessible, not so many. And this year is especially exciting because Dr ko our co founder of orange buying at the group of speaking at ADA brand new program the innovation Hall.   Stacey Simms  04:58 That's awesome. So Dr Koh, tell me. Little bit about this, the Innovation Hub is pretty cool, but what are you going to be talking about?   Unghyeon Ko  05:05 Yeah, actually, I'm talking about the engineering part. I mean our technology, so our orange biomed, we are trying to solve a simple but a serious problem about the A1C accessibility. So to increase the A1C accessibility. So we are, we are developing at home device to measure the A1C level. So I'm, I'm talking about how difficult to increase the accessibility of A1C, but our technology is handled that difficult problem. So we now he's so agreed. So I'm going to introduce our technology and emphasize the importance of the A1C measurement at home.   Stacey Simms  05:49 Yeah, so A1C, it's interesting. My son was diagnosed at two, and in the pediatric world, you know, they'll just prick a finger generally and have that A1C right away. But my husband lives with type two, and he gets his labs drawn. And then it takes forever. So tell me a little bit before we go further about what you're hoping to do and making this easier for the patient,   Speaker 1  06:10 the frequent monitoring of A1C is so important to prevent the diabetic complications. So the money, so if you there is some so I can say that there is a research that if you measure the A 1d the four times a year, the People's A1C level is decreased like 3.8% but if you measure the A 1d at one per year, Then the A1C level is increased 1.5% so the frequent A1C monitoring is so important to prevent the diabetes complications. But problem is A1C measurement is only available at clinical site at this moment, so most of the A1C monitoring is done by the clinical side. So that's why people are difficult to monitoring A1C, because they have to visit the clinics forever. So is so like four times, or even eight times visit the clinics or hospital is quite difficult, especially in the people living in the far area from the hospital. So that's why the home A1C test is required. So I think that's why the accessibility of the A1C is one of the important things in managing the diabetes complications.   Stacey Simms  07:39 Dr Koh, is there evidence that, I mean more frequent A1C testing, I think would give many people peace of mind, perhaps. But is there evidence that it really does help in your health?   Speaker 1  07:51 Oh, yes, it is actually like from there is the research, like the famous research about the A1C level, like the research name this t and this research proved that the A1C is the one of the strongest predictor of diabetes complication. So A1C is completely related with the risk of diabetes complication. So like keeping A1C on the 7% dramatically lower the risk of diabetes complications. And also, there is another research in UK, the UK PDS study, and that study said they are A1C. Lowering A1C by just 1% can reduce overall mortality by 15% and microvascular complication by 37% so the roaring A1C is the goal of the treatment of the   Yeaseul Park  08:47 diabetes. So   Stacey Simms  08:48 when I think of at home diabetes tests, blood tests, seem like they're they're really sensitive, right? You have to be very careful with things like that, although we do, we did finger sticks at home for years and years. Are there challenges with at home A1C testing that that people like me could mess up,   Yeaseul Park  09:06 sure actually when I was doing pandemic outside system? So it's a new   Yeaseul Park  09:19 box of mustard with five or six needles inside, and we need to collect this blood to sound the left result. But then I really tried to collect the requirement matter blood, which is like it was like bleeding. Oh, it's not just retiring in one block, one drop of block, but it's like you need to try, yeah, many times, not just in one spot, to collapse in the block. And the other way you. Built female in, built a lot more broadly, to store your venous blood, and that's features like discomfort.   Stacey Simms  10:10 Would you mind taking us through your experience with the A1C testing? You were talking about how much blood it took? Yeah.   Yeaseul Park  10:17 So it, it requires many, many drops of blood. So I felt like it's like bleeding, and you make a lot of mess around the table. And so I felt, even though it's it was a topic time it was pandemic. So that's the only option I had at that time, but I wanted to make it simple and easier. And the other types of point of care devices only use a drop of blood still have some limitations, because we all don't want to bleed too much, so sometimes we try to finger stick very small and just squeeze to get enough blood. But if you squeeze to get enough sample volume, that's make your other liquid, like sweats, can also mix with your blood, and that actually affects the accuracy of the testing usually so many point of care devices also not recommend you to squeeze to get enough blood, so that means you need to treat a little too deep to get enough. So we really wanted to make this whole process or simpler and more problem.   Stacey Simms  11:43 Can you share a little bit about what the device looks like, what the patient experience is when they use it?   Speaker 1  11:48 Dr, CO, so our device is a palm size. Is in most like, like self, self poem, so it's a palm size device. So our device has no switch, but there is only a slider in the front of the device. So if you slide that, you can the device is turned on and you can insert the cartridge, and the cartridge is disposable cartridge. So after that, you just collect your blood and dilute it in the collecting tube and drop the sample into the cartridge, then analyze the A1C like automatically. So it's quite similar with the covid by covid test kit. So the covid test kit collect the sample in your nose and mix with the Rickett and drop it right? And it's quite similar.   Stacey Simms  12:45 So do you do a finger stick to put on the cartridge? How much blood to yells? Point, you know? How much blood do you need?   Speaker 1  12:52 Our devices for home use device, so it's quite we use a very different technology, because our device analyze the red blood cell one by one. So actually, we don't need exact unlike like five micro or 10 micro, we don't need the exact sample block. So we just need one drop of blood. So if the one drop is big, or if the one drop is right or small, it's fine for us. So one drop of blood, mix with their sample and drop one drop onto the cartridge. So maybe you can, you can drop one more than one drop, but we recommend one drop. So one drop of blood sample my dinner the rest yesterday pointed out that the skeezing the finger of blood is a problem for other device because, because in our body, there is a body wicked inside your under, under your skin. So if the body wicked is mixed with the blood samples, so it might be a problem because it dilute the blood sample. But our device, we analyze the Red Cross itself. So if it is diabetes, I think so we will find so you just puncture very best, and if you scale it, and it's totally fine for us. So it's, it's one of the good point of our device.   Yeaseul Park  14:20 How long does it take to get the results? It takes like, five minutes. Okay, yeah, and that's all at home. Yeah. Yezel, who do you see using this? Who is this for? Basically, it's for everyone. I think whoever has pre diabetes, diabetes type one, type two, and especially, I think who has limited access to primary care or lab testings. You know, many people who are older, tends to have more, especially the people who has limited access to primary care or lab testings. We believe this device can give more value to them. Yeah, and especially some people who have limited mobility, if they are older, or if they have experienced that amputation or something like that, they cannot go to the hospital by themselves. They need a caregivers to drive them to the hospital for the simple lab testing. But now I think it empowers patients who has that limitation still can take control their health by using this kind of home use device. How accurate   Stacey Simms  15:33 is it? I assume you have studies, and you've done some trials on how on the accuracy?   Yeaseul Park  15:37 Dr, CO, do you want to add that?   Speaker 1  15:40 Oh, yeah. So we are preparing the clinical trial. So the official clinical trials will be done within this year, but so that's our plan. But we we tested our device already using the in in last year. So last year, feasibility studies show that our device is quite similar with other point of care devices, and hopefully because at that time, our device, our especially our cartridge sensor, we just manufacturing our own like our in our lab. So this time, the official clinical trial in in this year, we are going to manufacturing in the factories so it might be more precise. So we hopefully we trying to chase the hospital accurate.   Stacey Simms  16:30 And I have to ask, where more and more people with diabetes are wearing a CGM and looking at time and range. What would you say to people who would tell you, well, we don't really need A1C anymore. We have time and range. Dr Cody, I see you nodding. Go ahead, yeah, yeah.   Speaker 1  16:47 So that's a very important point, but because the timing range is also important, and the CGM is very great technology for diabetes people. But problem is, like the A1C and C GM target different, like the CGM target the hypothesemia, but the A1C targeting the diabetes complications. So like, if you measure the timing range and you can manage your average glucose more nicely, but it might be prevent your hypothenia. But if you want to assess your diabetes management, you might be measure A1C. So if you measure timing range, but you also have to measure the A1C. So A1C is for everyone's and so. And also, the point is, if you don't treat the insulin, or if you don't treat the any medications, then you don't need to actually using the CGM, that's the ADH recommendation. So, but in in that case, you need the A1C as well. So A1C for everyone, and the CGM is for the people who treated the insulin. That's the ADA guide, right? And then,   Stacey Simms  18:12 yes, let me just ask you. You know, you came all this way. As you say, this is your third time at ADA. Trials are starting soon. What's your hope here? Is this something you see in homes of everyone who has any kind of diabetes? What's the big goal for Orange biomed?   Yeaseul Park  18:28 Every time we talk to a day, we can feel what's going on here in diabetes industry. It's a huge maybe first year, I the most frequently hard keyword was aid system. But after that, we now have GLP one, and now we hear more keyword around obesity. So that's a little slightly different trend I can feel. And once you come and join this full sessions, then I can see there's make everyone is making a progress, and we are all together. Want to fight against diabetes in their own way or with their own expertise, whether it's pharmaceutical, whether it's medical device or diabetes, sex, sometimes any other community programs that really support this patient and families, the community, and it's Really this whole atmosphere actually really motivates our team and myself, and we can feel the value. I can really feel this we are doing something valuable to patients and our community, and that's the most great thing, like the greatest thing that I can take when I come back to home with a. After the ADA. And for sure, we want to have opportunity to make voice what we are doing at Orange biomed, and want to deliver this value to the patient and other healthcare professionals. Otherwise, even though we are working hard to make this progress, no one knows, and that makes any changes the world. So that's the important purpose we are coming here. That's great.   Stacey Simms  20:30 Janice, before I let you all go, I know you wanted to talk about an event you've got coming up in Chicago. Can you tell me a little   Janice Dru-Bennett  20:37 bit about that? Yes, we're really excited for Orange biomed to be hosting the first map your health event, a local event here in Chicago, we have done a solving healthcare challenges webinar to announce our map your health campaign, which is, monitor your A1C, monitor your health and then adapt your treatment and prevent chronic disease. And we're actually going to be hosting on August 16, from 10am to 3pm in Chicago at their humble Park, Health Wellness Center, the first local event, inviting all local partners. We'll have some virtual sessions, showcase with yoga or ask the endocrinologist. So we'll have a very exciting agenda that both virtual and on site participants can join in, eat healthy foods. See, see what's in Chicago from a screenings perspective, and really get people motivated to map your health. So hashtag, map your health. Tell your your your health story, and let's get everyone, um, healthier. Wow.   Stacey Simms  21:35 Okay, fantastic. Well, yes, I'll park Dr co Janice, thank you so much for joining me. Have a terrific show. I know this is an audio podcast, but especially behind you. Yassil, it has been wild to watch the construction guys are going by and motorized carts and things are going up behind you. So have a wonderful ADA. Keep us posted, and we'll get the word out about your event in August and going forward. Thanks so much for joining me.   more information in the show notes about the studies and about orange biomed. You can sign up for alerts and emails from them as their product moves forward. So if you're interested, definitely check that out. Thank you to my editor, John Bukenis from audio editing solutions, thank you so much for listening. I'm Stacey Simms. I'll see you back here soon. Until then, be kind to yourself.   Benny  22:30 Diabetes Connections is a production of Stacey Simms media. All Rights Reserved, all wrongs avenged.    

Send us a textHello, and thank you for joining us today for Episode 29 of our Christmas podcasts for 2025. My name is Stephanie Wright, and we are going to look at the role of the Holy Spirit in the birth of Jesus. Christmas took on a new meaning for me in 2024. The Lord compelled me to speak about the Holy Spirit in November 2024 and to continue into 2025. During these preparations, the significance of the Holy Spirit at Christmas became more apparent to me. After we read what the angel Gabriel said to Mary when he announced that she would be the mother of Jesus, we will discuss the role of the Holy Spirit in Christmas. We will close the podcasts by remembering Jesus' purpose in coming into this world: to restore the relationship between God and man through his—Jesus'—death on the cross for our sins. Then, He rose from the dead so we could win over sin. That takes us to our closing point. Jesus was born so you could live eternally—forever—with God one day. If you have not received Jesus as your Savior and Lord, today would be a good day to do so. Romans 10:9 says, if you confess with your mouth the Lord Jesus, and believe in your heart that God has raised Jesus from the dead, you shall be saved, that is, saved from a life of sinning against God to a life of serving Him and spending eternity with Him. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Renato (Ren) Circi, co-founder of SAVA, a London based MedTech company building a new generation of minimally invasive continuous glucose monitors and molecular wearables.In this episode we rewind to the underground labs at Imperial College London where Ren and his co-founder Raph first immersed themselves in biosensors and began questioning the status quo of health monitoring. Ren explains how their shared obsession with measuring the body more effortlessly led to SAVA's founding and what it really looks like to push through years of scientific failure in order to build a complex medical device platform.We dive into why SAVA manufactures everything in-house, how their micro sensor architecture differs from traditional filament based CGMs and why controlling every layer from chemistry to algorithms is essential if you want to iterate fast on performance. Ren sets out SAVA's long term vision of continuous molecular tracking for everyone, not just people with diabetes, and what could be unlocked once you can monitor many molecules in real time from a single patch.We also talk about regulatory expectations for CGMs, the reality of one way product decisions in medical devices and the difficulty of fundraising for a consumer facing yet highly regulated deep tech company. Ren closes with candid reflections on what he would do differently, how he protects time for family and why working on a problem you truly care about with people you genuinely like is the only way to survive the journey.Timestamps[00:00:21] Origins at Imperial and discovering biosensors[00:01:59] Long horizons, repeated failure and staying in the game[00:03:56] Why SAVA manufactures everything in-house[00:06:46] How SAVA's micro sensor CGM platform actually works[00:09:36] From diabetes to universal molecular health monitoring[00:12:02] Patient experience and CGM adoption in healthcare systems[00:13:43] When CGMs become cheaper than finger-pricks[00:15:15] Misconceptions about CGM and continuous molecular sensing[00:17:21] Why building CGMs is one of the hardest engineering challenges[00:22:54] Fundraising in unconventional deep tech MedTech and advice for foundersConnect with Ren - ⁠⁠https://www.linkedin.com/in/circi/⁠Learn more about Sava - ⁠⁠https://www.sava.health/Get in touch with Karandeep Badwal - ⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠Follow Karandeep on YouTube - ⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠Subscribe to the Podcast

What happens when you accidentally take 27 units of Fiasp instead of your long-acting insulin?On this solo episode of We Are T1D, Mike shares the raw, real story of the day he injected the wrong insulin — and how it turned into a full-on Type 1 diabetes survival mission.From that heart-sinking moment of realisation, to calling in sick, watching Dexcom arrows like a hawk, finger-pricking nonstop, smashing carbs, and even treating a low with a McFlurry

This episode covers: • FDA Loosens Supplement Warning Labels The FDA is considering a rule change that would allow supplement companies to include the DSHEA disclaimer only once per package rather than next to every claim. Dave explains why fewer visible warnings could make marketing look more like medical claims, and why biohackers should treat labels as advertising rather than evidence. He shares how to protect yourself now: add one variable at a time, run baseline labs, and rely on data instead of packaging. Source: https://www.nbcnews.com/health/health-news/fda-supplements-warning-label-rule-change-rfk-jr-rcna249321 • Quantum Sensors for Early Heart Attack Detection Mayo Clinic is testing a contactless heart-monitoring system called CardiAQ using quantum magnetic sensors and AI noise filtering. The device reads subtle electromagnetic signatures from the heart and compares them to invasive angiography. Dave breaks down why earlier detection of ischemia could shift heart care from reactive treatment to proactive screening — and why building baseline metrics like VO₂max, blood pressure and HRV today will pay off when next-gen diagnostics arrive. Source: https://www.sandboxaq.com/press/sandboxaq-collaborates-with-mayo-clinic-on-novel-cardiac-diagnostics • Sauna Detox for MicroplasticsEmerging research shows that sweating meaningfully removes plastic-related chemicals like BPA and phthalate metabolites from the body, often more efficiently than blood or urine alone. Sauna use amplifies this effect by increasing circulation, mobilizing stored toxins from tissues, and accelerating sweat-based excretion. When you combine regular heat exposure with reduced environmental plastic contact, you create a powerful detox strategy that targets a chemical burden once thought unavoidable. Dave breaks down how sauna protocols can support toxin elimination, improve cardiovascular resilience, strengthen autonomic balance, and help counteract the metabolic and hormonal disruptions linked to microplastics in modern life.Source: https://superage.com/can-you-sweat-out-microplastics-in-the-sauna/ • Psychedelics and Longevity Biomarkers Bryan Johnson treated a guided psilocybin experience as a structured longevity experiment, collecting nearly 250 biomarkers including CGM, stress markers, HRV and Kernel brain imaging. The experiment revealed a surprising metabolic change: mean glucose dropped 8 percent, variability fell 11 percent, and estimated HbA1c moved from 4.7 to 4.4 — similar to months of metformin but after a single session. Dave explores the emerging idea that neuroplastic events might influence glucose regulation through brain-pancreas signaling, while emphasizing the need for supervised, legal use and proper clinical trials. Source: https://www.businessinsider.com/bryan-johnson-trip-on-mushrooms-five-hours-live-2025-12 • A Mitochondrial Protein that Extends Mouse Lifespan Researchers boosted the mitochondrial protein COX7RP and extended mouse lifespan by ~6.6 percent while improving insulin sensitivity, lipid handling, endurance and liver fat metabolism. COX7RP supports formation of mitochondrial “supercomplexes,” improving respiratory efficiency and ATP generation. Dave explains how this reinforces lifestyle levers — strength training, aerobic capacity, stabilizing blood sugar — as tools that likely preserve supercomplex architecture and mitochondrial resilience. Source: https://www.eurekalert.org/news-releases/1109082 All source links provided for direct access to the original research and reporting. This episode is designed for biohackers, longevity seekers and high-performance listeners who want practical strategies rooted in cutting-edge science. Dave Asprey translates emerging research into actionable upgrades for your biology — from metabolism and mitochondria to nervous system health, detox, and prevention. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: FDA supplement rule change, supplement warning labels, DSHEA disclaimer removal, supplement regulation risks, quantum cardiac scanner, Mayo Clinic heart attack detection, AI heart monitoring, early ischemia detection technology, sauna detox evidence, sweating out toxins research, BPA phthalate sweat studies, microplastics sauna myth, Bryan Johnson psilocybin experiment, psychedelic longevity research, psychedelic metabolic reset, glucose control psychedelics, HbA1c psilocybin results, continuous glucose monitor insights, mitochondria lifespan research, COX7RP protein aging study, mitochondrial supercomplex benefits, ATP energy output aging, metabolic flexibility longevity, biohacking news update, anti-aging science breakthroughs, evidence-based longevity tools, biological age biomarkers Thank you to our sponsors! -BEYOND Conference 2026 | Register now at https://beyondconference.com/ -BodyGuardz | Visit https://www.bodyguardz.com/ and use code DAVE for 25% off. Resources: • Subscribe to my weekly newsletter: https://substack.daveasprey.com/welcome • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 - Intro 0:18 - Story 1: FDA Supplement Label Changes 1:43 - Story 2: CardiAQ Heart Scanner 2:59 - Story 3: Saunas and Microplastics 4:58 - Story 4: Psychedelics and Blood Sugar 8:22 - Story 5: Mitochondrial Longevity Research 10:29 - Weekly Wrap-Up See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of the Evolving Wellness Podcast, host Sarah talks with Isaac Pohlman, a registered dietitian and type 1 diabetic, about the misconceptions and nuances surrounding blood sugar, carbohydrates, and diabetes management. They discuss the CGM craze, the importance of understanding dynamic body systems, and the dangers of extreme dietary restrictions. Isaac shares his personal journey from a high school athlete to a dietitian specializing in blood sugar issues and busts myths around carbs, insulin, and common dietary advice. The conversation also touches on the significance of lifestyle factors like sunlight exposure, stress management, and the role of physical activity in insulin sensitivity and overall metabolic health. Join Sarah and Isaac for a balanced, common-sense approach to understanding and managing diabetes without succumbing to oversimplified online narratives.The Pohlman Institute's Mission:Founded by Isaac Pohlman, a Registered Dietitian and Type 1 Diabetic, The Pohlman Institute helps people achieve balanced blood sugar and long-term wellness through root-cause functional nutrition. After overcoming his own struggles with gastroparesis, food sensitivities, and diabetes, Isaac created a holistic system that empowers individuals to understand and heal their bodies from the inside out. The Institute's mission is to guide clients toward true metabolic freedom—helping them live vibrant, unrestricted lives by addressing the underlying causes of blood sugar and hormonal imbalancesConnect with Isaac : https://www.instagram.com/isaacpohlman/Website : https://www.thepohlmaninstitute.com/_________Sponsored By:→ Troscriptions | There's a completely new way to optimize your health. Give it a try at http://troscriptions.com/SARAHK, or enter SARAHK at checkout for 10% off your first order.→ Bon Charge| Go to https://us.boncharge.com/products/red-light-face-mask?rfsn=8108115.26608d & use code for SARAHKLEINER for 15% off storewide._________Timestamps00:00 Introduction to Blood Sugar Dynamics01:34 Meet Isaac: A Journey with Type 1 Diabetes04:55 Isaac's Early Struggles and Diagnosis08:58 The Role of Carbohydrates in Diabetes Management00:00 Debunking Myths: Keto, Carnivore, and Blood Sugar15:45 The Importance of Metabolic Flexibility20:40 Lifestyle Factors Affecting Blood Sugar35:08 The Balance Between Natural and Medical Interventions37:37 The Role of Insulin in the Body40:02 Insulin Sensitivity and Resistance41:12 Balancing Hormones for Optimal Health41:51 Carbohydrates and Blood Sugar Management44:05 The Importance of Lifestyle in Diabetes Management47:16 Vitamin D and Blood Sugar Levels49:52 The Impact of Potassium and Thyroid on Blood Sugar01:04:25 Addressing High Blood Sugar and Misdiagnosis________________________________________This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________Get all my free guides and product recommendations to get started on your journey!https://www.sarahkleinerwellness.com/all-free-resourcesCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) - https://www.sarahkleinerwellness.com/coursesSign up for my newsletter to get special offers in the future! -https://www.sarahkleinerwellness.com/contactFree Guide to Building your perfect quantum day (start here) -https://www.sarahkleinerwellness.com/opt-in-9d5f6918-77a8-40d7-bedf-93ca2ec8387fMy free product guide with all product recommendations and discount codes:https://www.sarahkleinerwellness.com/resource_redirect/downloads/file-uploads/sites/2147573344/themes/2150788813/downloads/eac4820-016-b500-7db-ba106ed8583_2024_SKW_Affiliate_Guide_6_.pdf

Send us a textCharles George Missions Presents: Day 17 – Christmas Podcast – “He Decorated the Sky”Hello and welcome to Day 17, of CGMissions Christmas Podcast. Today's podcast is entitled “He Decorated the Sky.” Today we are going to talk about God decorating the sky with the Star of Bethlehem or as some say, The Christmas Star, on the night Jesus was born. And please stay with us because at the end of today's podcast we are going to tell you about the reappearance of that star and how you can see it.If you are joining us for the first time, we invite you to listen to our previous daily podcasts which began on December 1st. In each podcast we have a new contributor share their favorite Christmas memory. These podcasts are brought to encourage you and to celebrate the birth of Jesus. Stay with us to the end to hear Christmas music and announcements.Today's Christmas memory share is from Rebecca who hails from Greece and Germany. Let's join Rebecca now.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

SHOW NOTES: In this episode, we're talking about Continuous Glucose Monitors (CGMs) and why they can be a powerful learning tool for non-diabetic women who feel tired, inflamed, anxious, or stuck in their health. A CGM doesn't just show a number. It shows patterns. How your body responds to food, stress, sleep, movement, and even emotions. And often, those patterns tell a story long before standard labs ever raise a red flag. We'll cover: What a CGM is and how it actually works How to apply a CGM Why blood sugar regulation matters even without a diabetes diagnosis What CGMs can reveal about metabolism, hormones, and nervous system health How to use CGM data  This conversation is about stewardship, not control. Awareness, not anxiety. And learning how to listen to the body God designed with clarity and grace. Whether you're curious about trying a CGM or simply want to better understand how blood sugar impacts energy, mood, and long-term health, this episode will give you a grounded place to start. Apply for coaching here - https://www.morriswellnessservices.com/apply Get on the Verity Village waiting list here - https://www.morriswellnessservices.com/villagewaiting This is the newly rebranded podcast, formerly known as "Your Birth, God's Way". If you are pregnant, please look back on your podcast app for over 140 episodes dealing exclusively with pregnancy topics! Helpful Links: — BIBLE STUDY - FREE Bible Study Course - How To Be Sure Of Your Salvation - https://the-ruffled-mango-school.teachable.com/p/how-to-be-sure-of-your-salvation -- COACHING - If you're tired of shallow, cheap, meaningless connections in pregnancy that leave you feeling passed over and confused, Virtual Prenatal Coaching might be for you. If you're ready to invest in coaching that will bring REAL results and REAL change, not only now but for the future of your family and your children's families, let's talk about how this 1-on-1 coaching might be just what you've been looking for! Go here to learn more - https://go.yourbirthgodsway.com/coachinginterest   -- If you are not pregnant, you're sick and tired of being sick and tired, and you're ready for something different - something to help you finally look and feel like yourself again, my 1:1 Concierge Wellness Coaching is for YOU! Learn more at morriswellnessservices.com! — CHRISTIAN CHILDBIRTH EDUCATION - Sign up HERE for the Your Birth, God's Way Online Christian Childbirth Course! This is a COMPLETE childbirth education course with a God-led foundation taught by a certified nurse-midwife with over 20 years of experience in all sides of the maternity world! - https://go.yourbirthgodsway.com/cec   — HOME BIRTH PREP - Having a home birth and need help getting prepared?  Sign up HERE for the Home Birth Prep Course. — homebirthprep.com   — MERCH - Get Christian pregnancy and birth merch HERE - https://go.yourbirthgodsway.com/store   — RESOURCES & LINKS - All of Lori's Recommended Resources HERE - https://go.yourbirthgodsway.com/resources   Got questions?  Email lori@yourbirthgodsway.com Leave me a message -- https://www.speakpipe.com/yourbirthgodsway   Social Media Links:  • Follow Lori on Instagram! @lori_morris_cnm  • Join Lori's Facebook Page! facebook.com/lorimorriscnm  • Join Our Exclusive Online Christian Women's Wellness Community -- facebook.com/groups/yourbirthgodsway   Learn more about pregnancy at go.yourbirthgodsway.com! Learn how to reclaim your health at every season of motherhood at morriswellnessservices.com !   DISCLAIMER:  Remember that though I am a midwife, I am not YOUR midwife.  Nothing in this podcast shall; be construed as medical advice.  Listening to this podcast does not mean that we have entered into a patient-care provider relationship. While I strive to provide the most accurate information I can, content is not guaranteed to be 100% accurate.  You must do your research and consult other reputable sources, including your provider, to make the best decision for your own care.  Talk with your own care provider before putting any information here into practice.  Weigh all risks and benefits for yourself knowing that no outcome can be guaranteed.  I do not know the specific details about your situation and thus I am not responsible for the outcomes of your choices.    Some links may be affiliate links which provide me a small commission when you purchase through them.  This does not cost you anything at all and it allows me to continue providing you with the content you love.

Rachel shares her chaotic journey through three pregnancies misdiagnosed as Gestational Diabetes before a life-threatening DKA event revealed she has LADA (Type 1). She discusses the dangers of misdiagnosis, the "smash and dash" humor of her marriage, and managing her fourth pregnancy with the right tools. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.   

Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

If you want to get leaner and live longer check out https://milliondollarbodylabs.com   Will an AI doctor soon replace your physician? I talk about how personalized testing and artificial intelligence are making true preventative health cheaper and more accessible.   I talked with Hunter Ziesing, who shifted from a successful career in finance after losing family and friends to preventable diseases. He now runs Longevity Health, a virtual clinic providing comprehensive diagnostic testing, including 60 blood biomarkers, DEXA scans, and VO2 max, for $11,000 annually. The goal is to make health preventative, not reactionary, moving beyond the current sick-care model. We discuss how their AI platform analyzes this massive data to create customized health plans, significantly reducing costs and giving constant, gentle reminders to change daily habits, making prevention affordable and effective. We also cover the challenges of getting consumers ready for a doctorless AI model and the essential role of human doctors in the future.   Key Takeaways Longevity Health offers a fully HIPAA compliant, physician-led virtual clinic for $11,000 per year, which is a fraction of the cost of some high-end clinics. The virtual clinic provides comprehensive testing, including a DEXA scan (for bone density and visceral fat), a CGM glucose monitor (worn for about two months), a blood test (analyzing around 60 biomarkers), a VO2 max test, a sleep study, and gut biome analysis. The tests are tailored to the individual's specific health concerns and family history. DEXA and blood tests are the metrics repeated most often every quarter to see real change. The "trillion dollar business" is what they are building around AI. AI has the potential to significantly reduce the cost of personalized medicine and make health information more accessible to the masses. AI is not fully ready yet, as it still "hallucinates," and regulations are not yet finalized. Furthermore, consumers are not fully ready for the "driverless doctor" and still desire a human physician in the loop for critical decisions. The preventative health approach requires giving people a "check engine warning light" via an app, offering constant, gentle reminders to reinforce healthy behaviors before a disease is diagnosed.   Resources Website: https://www.longevityhealth.me LinkedIn: https://www.linkedin.com/in/hunterziesing   Nate Palmer: The founder of The Million Dollar Body and author of "The Million Dollar Body Method", Nate has been coaching for over 15 years and has worked personally with over 1,000 clients. Website: https://milliondollarbodylabs.com/ Book: The Million Dollar Body Method Lean Energy Stack: https://milliondollarbodylabs.com/pages/lean Instagram: @_milliondollarbody  

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big FDA recall around Freestyle Libre (see more below to find out if you're affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb meals) and lots more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. Our top story this week: XX Certain glucose monitors from Abbott Diabetes Care are providing users with incorrect glucose readings, an error that has been linked with the deaths of at least seven people and more than 700 serious injuries worldwide, according to an alert from the US Food and Drug Administration.   Incorrect glucose readings can lead to improper treatment. Abbott warned that about 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors are affected, but no other Libre products. Patients can visit FreeStyleCheck.com to see if their sensors are affected and to get a replacement for free.   The FDA has also published specific information about the affected products in its alert. The agency considers this to be a "potentially high-risk issue" and will continue to update its website as information becomes available.   "Patients should verify if their sensors are impacted and immediately discontinue use and dispose of the affected sensor(s)," the FDA said.   https://www.cnn.com/2025/12/02/health/abbott-diabetes-glucose-monitors https://www.freestylecheck.com/us-en/home.html XX Omnipod 5 is getting some enhancements.. and Omnipod 6 is announced. The FDA cleared updates including  a lower, 100 mg/dL target glucose option and what they call a more seamless automated experience. "This is the most significant algorithm advancement to our Omnipod 5 System since its launch in 2022," said Eric Benjamin, Insulet EVP and COO. Insulet said the new 100 mg/dL target glucose expands Omnipod 5's customization range. It now features six settings between 100 mg/dL and 150 mg/dL in 10 mg/dL increments. The company said this flexibility allows healthcare providers to tailor insulin delivery more precisely. It supports individuals seeking tighter glucose management or aiming to meet specific glucose goals. Omnipod 5's latest upgrades also help users stay in "Automated Mode" with fewer interruptions, even during prolonged high glucose events. Insulet plans to launch the updates to the algorithm in the first half of 2026. The company announced plans for an Omnipod 6 – without a lot of detail - at the company's Investor Day event in November. They also talked about a new, fully closed-loop pump for the type 2 diabetes population. https://www.drugdeliverybusiness.com/insulet-fda-clearance-omnipod-5-algorithm-enhancements/ XX Dexcom, the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System will launch in the United States on Dec. 1, making it the longest-lasting CGM system with 15.5 days of wear.   Dexcom G7 15 Day will first be available through durable medical equipment (DME) providers on Dec. 1 with full retail launch in the coming weeks. Dexcom G7 15 Day will also be covered for Medicare beneficiaries.   Dexcom G7 15 Day's industry-leading wear-time will provide fewer sensor changes, less disruption and more time for people with diabetes to benefit from life-changing CGM technology.   New with Dexcom G7 15 Day:  Longest lasting CGM system with 15.5 days of wear. Best-in-class accuracy1 with an overall MARD of 8.0%. Easier glucose management with fewer monthly sensor changes and reduced monthly waste. This follows yesterday's announcement – the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults 18 and older with Type 2 diabetes using long-acting insulin. Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as directed by their healthcare provider. At launch, Dexcom G7 15 Day will connect with the iLet Bionic Pancreas and Omnipod® 5§§. We are working closely with Tandem and look forward to extending the launch to their customers shortly as they finalize integration. For specific information on pump compatibility and availability with the Dexcom G7 15 Day system, visit Dexcom.com/connectedpumps https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Continuous-Glucose-Monitoring-System-to-Launch-on-Dec--1-in-the-United-States/default.aspx   XX A small study of ten adults with type 1 diabetes tested Tandem's new fully closed-loop "Freedom" insulin system — and the participants put it through a real-world stress test. For 72 hours in a hotel setting, they ate heavy carb-and-fat meals, skipped all meal announcements, and didn't give any mealtime insulin boluses. The system handled almost everything automatically. Researchers said the device stayed in closed-loop mode 97% of the time and there were no incidents of diabetic ketoacidosis or severe hypoglycemia reported. While using the Freedom system, participants spent a median 61% of the day in the glucose target range — slightly higher than the 56% achieved with their usual pump at home. But the biggest improvement came overnight: time in range jumped to 96% with the closed-loop system compared to just under 70% during their home-pump week. With almost zero time spent below 70 mg/dL, researchers concluded that the fully automated Tandem system was both safe and effective even with unannounced, high-impact meals — hinting at a future of diabetes management that demands less effort from users.   XX Novo Nordisk reported promising mid-stage results for its experimental drug amycretin (AM-ee-creht-in) in diabetes patients on Tuesday. Amycretin, targets both GLP-1 and amylin hormones. In this study, it helped patients with type 2 diabetes lose up to 14.5% of their body weight over 36 weeks with weekly injections, far outperforming a placebo. The oral version delivered weight loss of up to 10.1%. Rival Eli Lilly  is surging ahead with its own amylin-based drug, eloralintide, which is advancing to late-stage testing after helping patients shed as much as 20% of their weight in a mid-stage trial. https://www.cnbc.com/2025/11/25/novos-next-gen-obesity-drug-shows-positive-results-heads-to-late-stage-testing.html XX The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in net covered prescription costs. The prices go into effect in 2027, including a monthly price of $274 for Novo Nordisk's popular GLP-1 drug semaglutide, sold as Wegovy for weight loss and Ozempic for diabetes. medicare's recent net price for Ozempic, opens new tab was $428 a month, according to an analysis published in the Journal of Managed Care and Specialty Pharmacy. Medicare put the drug's list price, before confidential rebates and discounts, at $959 a month. Based on such nondiscounted list prices, Medicare said savings on the 15 drugs ranged from 38% to 85%. The annual price negotiations were established under President Joe Biden's signature Inflation Reduction Act (IRA) of 2022. Previously, Medicare was barred by law from negotiating with drugmakers. https://www.reuters.com/business/healthcare-pharmaceuticals/us-negotiated-medicare-prices-15-more-drugs-test-cost-savings-promise-2025-11-25/   XX LifeScan announced its Chapter 11 bankruptcy reorganization plan received U.S. Bankruptcy Court approval. LifeScan said it's positioned to emerge from its financial restructuring process by the end of the year. The CEO says, "This balance sheet restructuring provides a stronger foundation for LifeScan to support our base business, advance new growth strategies, and commence our journey to become one of the most comprehensive players in the glucose management space." https://www.drugdeliverybusiness.com/glucose-monitor-lifescan-emerge-from-bankruptcy/ XX An artificial intelligence (AI)-led Diabetes Prevention Program (DPP) was as effective as a traditional human-led program in achieving recommended goals for weight loss, A1c reduction, and physical activity, according to a randomized trial of adults with prediabetes and overweight or obesity. One example of a push notification: "Looks like you're at the grocery store, Rita! Want a quick list of high-fiber snacks or smart swaps to stay on track this week?" The app also provided location- and goal-based education, with gamification elements to promote engagement. Approximately one third of participants in both the AI and human-led groups achieved the primary outcome (31.7% and 31.9%, respectively). Results were consistent across sensitivity analyses and individual components of the composite endpoint. "As more AI-based programs emerge, head-to-head comparisons among different AI-DPPs will be informative. An AI-led approach will not suit everyone; some individuals benefit more from human interaction and accountability," said Mathioudakis, adding that future research should focus on best matching patients to the modalities they prefer. https://www.medscape.com/viewarticle/ai-directed-diabetes-prevention-program-effective-human-2025a1000xam XX A new study suggets metformin could help people with type 1, reducing the need for insulin.  The researchers were surprised to find that metformin did not improve insulin resistance or change blood sugar levels. This suggests that, unlike in type 2 diabetes, metformin doesn't combat insulin resistance in type 1 diabetes.   However, metformin did reduce the amount of insulin people needed to keep their blood sugar levels stable.   https://www.the-express.com/news/health/192157/diabetes-medicine-insulin-type-1 XX Beyond Type 1 launches #TheBeyondType campaign in India to combat type 1 diabetes stigma. Nick Jonas is one of the founders of Beyond Type 1, his wife, Priyanka Chopra Jonas is his partner in this new non profit. The initiative highlights inspiring individuals living with T1D and partners with local organisations to improve awareness, medical support, and community networks for affected families across the nation. India has more young people living with T1D than any other nation, yet understanding of the condition remains limited. Beyond Type 1 is partnering with grassroots organisations across high-need regions. These include HRIDAY in Delhi–NCR, Nityaasha Foundation in Pune, Gram Jyoti in Jharkhand, and SAMATVAM Trust in Bangalore—each group focusing on improving awareness, providing medical support and building stronger community networks for young people with T1D.

Hate tracking carbs? You're not alone. Wendy covers how to support your blood sugar without doing math at every meal. We'll talk about visual portion guides, how to use CGM trends to guide choices, and why some clients do better when they ditch the numbers. If you're looking for a flexible, less stressful approach, this one's for you.If you're living with diabetes or prediabetes and want personalized support from a Registered Dietitian Nutritionist covered by insurance, visit diabetesdigital.co to connect with our culturally aware and weight-inclusive team. And if you love the show, don't forget to rate and review us on iTunes or Spotify—it makes a huge difference! For additional resources and show notes, head to diabetesdigital.co/podcast.

Cecilia discusses fighting for a Dexcom immediately after her daughter's diagnosis and using podcast education to achieve a 5.4 A1C despite limited medical guidance. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. 

Jaime shares her 2-year-old son's type 1 diabetes diagnosis, daycare symptoms, CGM and pump choices, caregiver anxiety, marriage and football-family life on the Juicebox Podcast. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!